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Abstract 
 
Multiple pregnancies are associated with higher rates of perinatal mortality than singleton 
pregnancies. This is due to the higher rates of preterm delivery and its associated 
complications.  However it is not understood why there is a difference in gestation between 
multiple pregnancies and singleton,  and what mechanism is responsible for this.  
This thesis explores the possible different myometrial properties between multiple 
pregnancies and singletons, and the effect of progesterone on the uterine contractility by 
placing myometrial strips onto a force transducer, which recorded the trace reflecting the 
contractility of the strip.  In a physiological saline solution there were no significant 
differences between the myometrial contractility properties of multiple pregnancies and 
singletons.  
The effect of progesterone showed a dose response relationship in singleton and twin 
myometrium as when incremental doses of progesterone were applied, greater amounts of 
reduction in force was exhibited. It was found that there were significant differences between 
twin and singleton myometrium at 10, 100μM progesterone with there being a significantly 
greater effect in singleton myometrium. This reduced effect in twins may explain why there 
was no effect found to prevent preterm birth in twins (Norman et al 2008), and suggests that a 
higher dose may have more beneficial in twins  
 A possible explanation for this difference in non genomic action could be due to the greater 
quantities of stretch applied to twin myometrium earlier on in pregnancy, and thus reducing 
the expression of the progesterone membrane receptor. This possible theory was explored by 
applied stretch on myometrial strips in 100μM progesterone. Although the paired stretched 
samples displayed a smaller response to progesterone, this was however not significant.  
Preterm delivery could also be affected by the maternal diet, as poor maternal nutrition leads 
to poor intrauterine growth, and is more likely to be preterm. A literature search was 
performed for studies that focused on maternal nutrition, and weight gain. It was found that 
early weight gain was associated with larger birthweights, and that total weight gain should 
be directed by maternal Body Mass Index (BMI), however much work is still required to 
explore how much weight gain is required, due to successful varying suggestions. It became 
apparent that when dietary supports (e.g. dieticians) were used, there were smaller rates of 
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preterm delivery and preterm birth. Yet it was hard to clarify if this success was down to the 
dietary interventions or the content of the diet itself.  
This work has shown that twin and singleton myometrium respond differently to 
progesterone which plays a key role in uterine quiescence. This difference in response may 
be the underlying trigger for preterm labour and that to improve the rates of preterm delivery 
we also need to think about the mother‟s diet as well.  
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1.1 Abstract 
 
The uterus undergoes great stretch and expansion as a result of the growing fetus and 
placenta and the accumulation of amniotic fluid through pregnancy. The mechanism that 
initiates contractions and why these occur early in women who deliver preterm are still 
largely uncertain, despite increased knowledge on uterine structure and physiology of 
contractions. This chapter will discuss the general anatomy and physiology of the uterus and 
then focus on myometrial contractility, with special emphasis on multiple pregnancies and 
their associated complications, and on current tocolytic drugs with an overview of their 
actions.  
  
 
One of main aims of this work was to explore the actions of progesterone, therefore its role 
in labor is discussed as well as its molecular interactions in the uterus.  
 
This chapter will then conclude with the specific aims of the thesis.  
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1.2  The uterus 
 
For many centuries it was believed that the uterus was a multi-chambered organ, and moved 
around the body, but it was not until the renaissance that dissection became legal and the 
great minds of Leonardo da Vinci and Vesalius used their artistic and scientific skills to lay 
the foundations of our knowledge today.  It was found that the uterus was anchored in the 
pelvis by ligaments, and that it was a one chambered organ with its own blood supply and 
nervous system. 
 
1.2.1 Gross anatomy and embryology 
 
The human uterus in a sexually mature non pregnant female is 7.5 cm by 5 cm, and is found 
posterior to the bladder and anterior to the pouch of Douglas. In the majority of women it is 
anteverted, with 10% having a retroverted uterus where the fundus is anterior to the cervix.   
Anteriorly, the uterus is covered by the peritoneum which reflects the bladder surface, and 
forms a fold in-between the bladder and the uterus known as the uterovesical fold.  
Posterior to the uterus the peritoneum forms another fold separating the uterus from the 
rectum and sigmoid colon called the recto-uterine pouch or more widely known as the pouch 
of Douglas.  
 
The uterus is supported weakly by the anterior and posterior ligaments, with the broad 
ligament enveloping the uterus as well as the fallopian tubes, blood vessels and nerve 
endings.  The round ligament also extends from the anterior surface of the uterus from below 
and anterior of the lateral cornua to the pelvic side wall. This becomes thickened in 
pregnancy and stretches.  The strongest support comes from the utero-sacral ligaments that 
extend posteriorly to the sacrum, and the transverse cervical ligaments. 
 
The uterus is a highly anatomised organ, and blood can be redirected easily. The source of the 
uterine blood supply is the common iliac artery, which divides into the external and internal 
arteries, with the internal artery becoming the uterine artery and the ovarian arteries. The 
uterine artery divides anteriorly and posteriorly becoming the anterior arcuate artery and the 
posterior arcuate artery (Bannister 1995). 
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The uterus is made up of the body, isthmus and the cervix. There are three layers of the 
uterus: the serosal layer of peritoneum, myometrium and the endometrium. The myometrium 
is made up of smooth muscle cells, which are responsible for the uterus contracting in labour, 
and the endometrium is a highly vascularised glandular lining that is shed during 
menstruation.  
It develops from the paramesonephric duct and by 10 weeks the uterine tubes have formed 
(Mitchell 2005). 
 
1.2.2  The structure of the myometrium 
 
The myometrium is made up of two muscle layers, an outer longitudinal layer (stratum 
subserosum) and an interior circular layer (stratum supravasculare). The outer layer consists 
of a network of smooth muscle bundles whose size and number are regulated by steroid 
hormones and the distension of the uterus due to the expanding fetus during pregnancy. The 
myocytes vary from 5 to 100µm in diameter, 300 to 600µm in length, and have an average 
volume of 21000mm
3
.  
The myocytes consist of a thick myosin filament (15nm), a thick actin filament (6-8nm) and 
intermediate filaments of desmin, and vimentin (10nm), as well as microtubules. These 
smooth muscle cells are myogenic, and are able to spontaneously depolarize without 
requiring stimulation from a hormonal or neurological source (Garfield 2007). 
 
1.2.3 Membrane potential  
 
The resting membrane potential of the myometrium is largely determined by the membrane 
conductance to potassium ions (K
+
). It varies in pregnancy from around -40 to -50 mV in 
early pregnancy, becoming more negatively charged in mid pregnancy to -60 mV and then 
finally depolarizing somewhat to around  -45mV at term. This potential difference occurs due 
to a more negatively charged intracellular environment created by a higher extracellular 
concentration of positive ions such as calcium (Ca
2+
), sodium
 
(Na
+
) (Sanborn 2002), and 
maintained by an efflux of intracellular K
+
 ions (Brainard 2007). The extracellular 
concentration of Ca
2+
 is about 10
-3
M, and 10
-7
M in the intracellular fluid (Kawarabayashi 
1994). 
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When the membrane depolarizes to around -40 mV it reaches the threshold value for voltage-
activated long lasting (L type) calcium channels to open and due to the concentration and 
electrical gradients, calcium ions influx into the cell (Mathew et al 2004). 
There are two types of calcium channels: transient, and long lasting. The transient (T-type) is 
rapidly inactivated and has a single channel conductance of 12pS while the L type calcium 
channels has a conductance of 29pS and is slowly inactivated (Kawarabayashi 1994).  
Sodium ions help maintain tone, with two channels Na 2.1 and Nav2.3 found in the human 
myometrium, yet a high percentage are inactivated  at the  resting potential, and their full role 
in the myometrium is unknown (Brainard 2007). 
 
1.2.4  Potassium ions and repolarization  
 
In order for the cell membrane to repolarise it has to reverse the disruption of the cell 
membrane potential by using an efflux of positively charged potassium ions. During this time 
of repolarization an action potential cannot be started. There are a variety of different 
potassium channels that allow the potassium ions to leave the cell; Ca
2+ 
 sensitive, voltage-
gated, adenosine triphosphate (ATP) sensitive channels. 
 
The Ca
2+
 sensitive channels can be further
 
subdivided into three groups: large conductance 
(BKca), intermediate (IKca) , and small (SKca) channels, with the BKca having the 
predominant role in the human myometrium. BKca channels are sensitive to voltage as well 
as calcium. They have a basic structure of S1-S6 transmembrane domains plus an additional 
four hydrophobic domains (S7-S10) forming a carboxy terminus. It is composed of  α and β 
subunits, calcium sensitivity is increased when both subunits are expressed as a result of the β 
subunit, as a more negative voltage is required to open the channel. BKca are activated as a 
result of increased intracellular calcium levels (Khan et al 2001). Glucocorticoids and beta 
oestradiol upregulate the expression of BKca, which is encoded for by the signal gene 
KCNMA1 (Benkusky 2002, Xie1998). Isoforms of BKca channels have been shown to 
increase their expression in labor: these are less sensitive to calcium and voltage, and have an 
additional 44 amino acids in the first intracellular loop (Brainard 2007). 
 
Voltage gated channels have a similar basic structure as Ca
2+
 sensitive channels with six 
transmembrane domains (S1-S6) yet have an additional pore forming hairpin loop. S4 is 
positively charged, and is sensitive to membrane voltage changes.  
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ATP sensitive channels are a type of inward recitifiers, having two membrane spanning 
regions M1 and M2, either side of a hairpin loop. however they play a small role in 
repolarization (Khan et al 2001). The predominant isoform found in the myometrium is 
Kir6.1, and it is inhibited by intracellular ATP and stimulated by magnesium  adenosine 
diphosphate (Brainard 2007). 
Calcium efflux mechanisms are also activated, in order for the cell to stabilise and reduce the 
intracellular calcium concentrations.  Calcium efflux occurs via two transporters : Ca
2+  
ATPase (PMCA) 70% total efflux  and Na
+
-Ca
+
 exchanger 30% efflux.  
 
The plasma membrane Ca
2+
 ATPase (PMCA) pumps Ca
2+
 out of the cell at the expense of 
ATP, and also counter-transports a proton potentially changing intracellular pH. It has four 
isoforms with PMCA 1&4 located in the uterus, with PMCA 4 having a predominant role 
(Moller et al 1996). The isoforms have ten membrane spanning regions, and the amino acid 
sequence is 80-90% homologous. PMCAs are regulated by calmodulin, protein kinase C as 
well as cGMP. PMCA 4 is mostly triggered by calmodulin and has the least basal activity.  
 
The Na+-Ca+ exchanger is an electrogenic antiporter located on the plasma membrane. It 
exchanges three extracellular sodium ions for one intracellular calcium ion. The Na
+
 
concentration gradient is maintained by a Na/K ATPase (Na+ pump).  The sodium-calcium 
exchanger has nine membrane domains, and 98 amino acids (Floyd et al 2007). 
 
1.2.5  Myometrial contractility 
 
When calcium ions enter the cell they form a complex with a protein called calmodulin. This 
complex activates the enzyme Myosin Light Chain Kinase (MLCK). The now activated 
enzyme causes the phosphorylation of serine 19 on the myosin head, leading to cross bridges 
forming between myosin and actin and ultimately resulting in contraction of the myocyte 
(Wray 2007). See figure 1.1  
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Figure 1.1: The mechanism of contraction ( adapted from Wray 2007) 
In order for the muscle to relax the MLCK pathway needs to be reversed and the myosin-
actin bond broken. Myosin phosphatase dephosphorylates the myosin light chain inhibiting 
the cross bridge cycling. Calcium voltage gated channels also now close due to decreasing 
calcium levels, and this subsequently causes dissociation of the Ca
2+
-calmodulin complex, 
and leading to inactivation of MLCK (Wray 2007). 
 
1.2.6 The role of the sacroplasmic reticulum 
 
The sarcoplasmic reticulum (SR) is an internal source of calcium, and occupies 5-7% of the 
cell volume. A Ca-ATPase pump on its membrane enables it to accumulate calcium from the 
cytoplasm and this also helps maintain a low resting Ca
2+
 in the cytoplasm.  Many agonists 
allow the calcium to be released and help increase the force of the contraction by making it 
more readily available to form calmodulin complexes. For example, oxytocin binds to 
receptors on the cell membrane thereby activating phospholipase C. This produces inositol 
1,4,5,-triphosphate (IP3) from phosphatidylinositol (3,4,5)-triphosphate. On the SR 
membrane there are IP3 gated release channels, which when activated cause calcium to be 
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released into the cytoplasm (Wray 2007). There are also Ca-gated receptors (ryanodine 
receptors) on the SR membrane but their role in the uterus appears to be non-functional. 
 
1.2.7  The role of cyclic adenosine monophosphate (cAMP) and progesterone  
 
Intracellular cAMP enhances muscle relaxation through the cAMP-dependent protein kinase 
A (PKA) pathway.  PKA is activated by cAMP when it binds to the regulatory units. The 
activated PKA causes phosphorylation of myosin light chain kinase, decreasing its activity 
and thus reducing the amount of phosphorylated myosin and thus contraction.  
 
cAMP is produced when G protein coupled receptors interact with an agonist producing 
adenyl cyclase (AC). AC converts ATP to cAMP. AC has nine difference isoforms, and is 
found in low levels in all human tissues, and contains a NH2 and has two hydrophobic 
domains consisting of 6 transmembrane helices separating two 40kDa cytoplasmic domains.   
The formation of cAMP is reversed by the enzyme phosphodiesterase breaking cAMP to 5 
adenosine monophosphate (Price et al 2001). 
 
Progesterone has been found to increase the accumulation of cAMP within the myometrium, 
and the concentration was reduced when progesterone was removed (Fu 1998). This rise in 
cAMP occurs as a result of the inhibition of phosphodiesterase (Gellerson et al 2009). In vitro 
work using myometrial samples taken from women in labor has also shown that cAMP is 
more sensitive to progesterone at 300μmol, while oestrogen at a concentration of 250μmol 
has no effect (Kofinas 1990). 
 
1.2.8  Gap junctions 
 
The transport of ions and molecules required for cell coupling, communication and survival 
are aided by gap junction proteins called connexins (CX) that form intercellular pathways 
helping molecules to move from cell to cell.  Mammalian studies have found that when there 
was a gestation-dependent increase, there was an increase in the conduction capabilities 
between cells and that there was an increase in quantity at preterm and term labour (Blanks et 
al 2007). 
The connexin believed to have the most impact on the myometrium is CX-43, and work in 
knockout mice found that if absent there was a delay in delivery (Doring et al 2006). 
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1.3 Current tocolytics and preterm birth 
 
Current guidelines from the Royal College of Obstetricians and Gynaecologists (RCOG) 
recommend the use of tocolytics in apparent preterm labor to buy time to allow 
corticosteroids to improve fetal lung maturity or to facilitate in utero transfer.  Currently there 
are no guidelines to support long term use of tocolytics (e.g. over one week). The guidelines 
do not advocate tocolytic use if there is any suspicion of infection.  
 
Over the choice of drug to use, the guidelines state: 
 
„If a tocolytic drug is to be used, ritodrine no longer is the best choice. Atosiban or nifedipine 
appear preferable as they have fewer adverse effects and seem to have comparable 
effectiveness. Atosiban is licensed for this usage in the UK but nidedipine is not.‟ (RCOG 
2008) 
 
1.3.1 Atosiban 
 
Atosiban is an oxytocin receptor antagonist, and therefore competes with oxytocin for 
receptor sites in the decidua and myometrium (Blumenfeld et al 2009). Oxytocin is a 
hormone produced by the posterior pituitary gland, and increases the force and frequency of 
uterine contractions by causing receptors in uterine myocytes to open and cause a calcium 
influx thus stimulating contractions. This effect was augmented in multiple pregnancies 
(Turton et al 2009). 
 
1.3.2  Ritodrine 
 
Ritodine is an example of a beta agonist and causes intracellular cyclic AMP levels to 
increase and inactivates MLCK, by binding to beta 2 adrenergic receptors on the myocyte 
cell membrane. By inactivating the intracellular MLCK, it prevents the phosphorylation of 
calmodulin (Blumenfeld et al 2009). Ritodrine was widely used in the past although it had 
frequent side effects, including palpitations, tremor, nausea, headache, and even chest pain. 
Pulmonary oedema was a rare but very serious adverse event (RCOG 2008). 
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1.3.3 Magnesium sulphate 
 
Magnesium sulphate works by inhibiting the voltage gated calcium channels, and MLCK. It 
is widely used in America, despite little evidence for its efficacy. A Cochrane review 
accessing the usefulness of magnesium sulphate for the prevention of preterm birth found it 
to be ineffective (Crowther 2002), although a more recent Cochrane review found it to have 
neuroprotective properties, reducing the risk of cerebral palsy (Doyle et al 2009). For the 
mother there is a risk of magnesium toxicity which, if serious can lead to respiratory 
depression and even cardiac arrest.  
 
1.3.4 Calcium channel blockers 
 
Calcium channel blockers (e.g. nifedipine) cause the relaxation of smooth muscles by 
inhibiting voltage dependent calcium channels thus preventing the re-uptake of calcium 
(Blumenfeld et al 2009). Nifedipine is not currently licensed in the United Kingdom for 
prevention of preterm delivery, although it is used, and one third of women will experience 
side effects, such as headaches. The optimal dose has yet to be defined. A Cochrane review 
found that calcium channel blockers reduced the incidence of neonatal respiratory distress 
syndrome, necrotising enterocolitis and intraventricular haemorrhage yet there was no 
significant difference in admission to the neonatal intensive care unit compared to other 
tocolytics (King et al 2003). 
 
1.3.5  Progesterone 
 
Progesterone is a hormone produced by the corpus luteum in the ovaries and by the placenta, 
and is discussed in further detail in another chapter. A recent Cochrane review which 
evaluated the use of progesterone for prevention of preterm birth concluded that further 
research was necessary to find the most effective method of administering progesterone in 
singleton and multiple pregnancies (Dodd 2009). 
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1.3.5.1 A history of progesterone 
 
In 1672 the first published work was issued describing the corpus luteum by Regner De 
Graff, associating it with the uterus and the fetus, however it was not until 1947 work by 
George Corner that it was shown that the corpus luteum produced progesterone and was 
responsible for maintaining early pregnancy by preparing the endometrial for implantation, 
and that it played a role in modifying myometrial activity (Corner 1974). 
 
1.3.5.2  Role of progesterone in labor 
 
Experiments with mice, rats, and rabbits have found that the progesterone produced by the 
corpus luteum helps to maintain pregnancy, and that there is a withdrawal prior to delivery as 
a result of destruction of the corpus luteum by prostaglandin F2α.  Early human pregnancy 
follows a similar pattern, with the progesterone from the corpus luteum maintaining early 
pregnancy, however after the ninth week synthesis of progesterone occurs at the placenta.   
 
Even though it has been observed in animals there is a reduction in progesterone levels prior 
to parturition, no such observations have been seen in humans until the delivery of the 
placenta occurs. In twin pregnancies progesterone plasma levels are double that found in 
singleton pregnancies at 26 weeks yet the progesterone-oestrogen ratio  remains similar and 
does not decrease prior to labour. However work by Smith et al also found that there was a 
decrease in progesterone levels at the onset of labor and a reduction in the median of the ratio 
of progesterone-oestrogen from 4:1 to 1:1 at labour, finding a similar fall in preterm and 
twins (Smith et al 2009). Despite there being no dramatic change in the levels of progesterone 
it has led to various hypotheses about the direct mechanism that causes labor. One theory is 
that a change in the progesterone receptor ratio initiates a reduced response to progesterone, 
which in turn inhibits myometrial contractility (Astle et al 2003). 
 
There are two types of progesterone receptor; progesterone A (PRA) and progesterone B 
(PRB). PRA is a dominant transrepressor of PRB mediated transcriptional activity in the 
myometrial cells, whereas PRB is the main ligand-dependent transcriptional activator of 
progesterone responsive genes. These isoforms originate from the chromosome 11q11-q23, a 
single gene that encodes for both isoforms. PRB has an extra 165 amino acids due to 
difference translational start sites and separate promoters. It is the ratio of the PR isoform‟s 
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messenger RNA that has been linked to progesterone withdrawal before labor, and which has 
been observed to increase the expression of PRA/PRB. 
 
 Transcription coupled polymerase chain reaction technology found that a functional 
progesterone withdrawal coincided with an activation of oestrogen promoting uterine 
contractility, with an increase in oestrogen receptor-α (Safakianaki 2006). However work by 
Condon et al failed to find PRA protein in nuclear form before or during labor, with mRNA 
levels low and unchanging(Condon et al 2006).They also found a truncated form of PRB in 
the human term myometrium, which lacks a larger N terminal segment than PRA. This other 
isoform of the progesterone nuclear receptor (progesterone receptor C)was found to increase 
prior to labor, and is absent from fundal myometrium (Zakar et al 2007). 
 
1.3.5.3 Progesterone and co-activators in labor 
 
When progesterone binds to an inactive receptor multi protein complex, it induces a change 
in the structure of the progesterone receptors within the cytoplasm, and thus stimulating the 
homodimerization of the PRs within the nucleus. The rate of gene transcription is dictated by 
regulating the number of RNA polymerase 2 complexes binding to the site, these complexes 
control the number of receptors that engage the co-activators. These co-activators help start 
the process of transcription by improving interaction between the protein complex and 
transcription apparatuses. The number of progesterone and steroid receptor co-activators 
appear to be reduced in the myometrium in labor compared to non labor along with the 
cAMP response element binding protein. This is another mechanism that may play a role in 
the initiation of labor (Sfakianaki et al 2006). 
 
1.3.5.4  Progesterone and its anti-inflammatory effect 
 
It is hypothesized that the anti inflammatory properties of progesterone may also play a role 
in labor. Progesterone inhibits nuclear factor kB (NF-kB). This transcription factor regulates 
the synthesis of prostaglandins by the enzyme cyclo-oxygenase 2 (COX-2), a process that 
results in inflammation. COX-2 is found in the amnion, the decidua of the chorion and the 
myometrium (Skakianaki et al 2006), with increased levels of COX-2 mRNA being 
upregulated in the fundus at labor (Hardy et al 2006). This inhibition of prostaglandins helps 
to maintain uterine quiescence. This is further supported by the use of the prostaglandin 
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antagonist mifiepristone in terminations of pregnancy. Prostaglandins help the uterus to expel 
the fetus by cervical ripening and uterine contraction (Gibb et al 1998). 
 
 
1.3.5.5 Progesterone and the myometrium 
 
Progesterone is secreted in early pregnancy by the corpus luteum allowing the embryo to 
implant, and ultimately produced by the placenta from 9 weeks. In later pregnancy it plays a 
role in uterine quiescence; reducing intracellular calcium by inhibiting voltage gated calcium 
channels (Jayasooriya 2009). 
 
It is thought that progesterone causes uterine relaxation by amplifying levels of cAMP, and 
preventing its hydroxylation by cyclic nucleotide phosphodiesterase. However a study by Fu 
et al found that progesterone also increased the frequency and tone, yet decreased the 
amplitude of contractions, as well as increasing cAMP release in human myometrium (Fu et 
al 1998). However it should be noted there is still much uncertainty over the direct action of 
progesterone on the myometrium, and significant work needs to be done to help resolve this.  
 
1.3.5.6 Progesterone‟s non genomic effect  
 
With progesterone being found to have a rapid inhibitory action on myometrium amplitude in 
vitro, it must be working via a non genomic pathway. The exact mechanism however has not 
been fully elucidated, and is surrounded by much debate. It is believed this rapid action 
occurs via a membrane progesterone receptor rather than the nuclear receptor. Originally 
found in Cynoscian nebulosus, different isoforms of the membrane progesterone receptors 
α,β, and γ have now been established in the human cells with mPRα being predominantly 
found in the human myometrium, β in neural tissue, and γ in the kidney and gastrointestinal 
tract (Fernandes et al 2008). These receptors consists of seven transmembrane progesterone 
adiponectin Q receptors, and directly coupled to G proteins (Thomas 2008). 
 
What is known is that the steroid can have many different effects on all species as well as 
different organs using the non genomic pathway. In the seatrout Rana pipiens progesterone 
initiated a temporary release of Ca
2+
 ions within the oocytes, following a decrease in the 
intercellular cAMP, and rise in cGMP. In spermatozoa, progesterone produced a dose 
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dependent rise in intracellular Ca
2+ 
which was not inhibited by RU486 (Mifepristone) a 
nuclear progesterone inhibitor. 17α hydroxyprogesterone (a synthetic form of progesterone) 
has also been shown to initiate a rapid Ca
2+ 
response in spermatozoa (Falkenstein et al 2000). 
 
It has been confirmed that progesterone has no effect on potassium channels as was 
previously hypothesized, with potassium channels inhibitors having no effect on the 
progesterone inhibition of contraction (Anderson et al 2009). Patch clamp techniques have 
also found that progesterone had no acute effect on potassium (Knock et al 2001).  
In vascular smooth muscle cells it was found that progesterone significantly reduced calcium 
influx through the L-type channels, when calcium levels were measured using a whole cell 
patch clamp technique decreasing the peak of the inward current to 65.7±4.3% (Barabagallo 
2001).  
 
In rat osteoblasts1nM progesterone increased IP3 female and male osteoblasts and cAMP 
levels were not affected by 1pM-µM progesterone (Grosse et al 2000). Yet in the human 
myometrium using medroxyprogesterone acetate there was no effect on IP3 and IP3 calcium 
stores (Fomin et al 1999).As discussed previously application of progesterone was followed 
by an increase of cAMP (Fu et al 1998), it may be that this is via the mPRα receptor. 
 
1.3.5.7 Genomic actions of progesterone 
 
These actions occur via the nuclear progesterone receptors PRA and PRB. PRB is believed to 
be the principal receptor that helps maintain uterine quiescence, although PRA modulates 
transcription of genes, it also regulates PRB activity. PRB enhances relaxation by inhibiting 
oxytocin and prostaglandin receptor expression as well as reducing the expression of 
connexin 43 and gap junction formation (Mesiano and Walsh 2007). 
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1.4  Multiple pregnancies 
 
Multiple pregnancies are when there are two or more fetuses present in the uterus.  This can 
be confirmed by using routine ultrasound to confirm the presence of two or more heart beats, 
and establishing the chorionicity/amnionicity of the placenta.  By using ultrasound it is also 
possible to detect any fetal abnormalities as well as the sex of the fetuses.  
 
1.4.1 Classification of multiple pregnancies 
 
Multiple pregnancies can occur as result of two individual oocytes being fertilized by two 
different sperm, known as dizygotic, or due to the division of a conceptus produced by one 
ovum and sperm, monozygotic. Triplets may be created from three separate zygotes or from 
two, with one of these dividing into monozygotic twins.   
 
Dizygotic twins are non-identical and can be of either sex, and always have two different 
placentas and amnions therefore are known as dichorionic and diamniotic.  
Whereas monozygotic twins are identical and can be dichorionic diamniotic or 
monochorionic diamniotic or even monochorionic monoamniotic depending on the time of 
the division. Figure 1.2 illustrates when division occurs and the resulting classification.  
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Figure1.2. Mechanisms of Twinning, Adapted from reference (Government of South 
Australian 2008). 
 
It is important to establish the correct classification of the twins as there are specific 
complications associated with each classification that require monitoring. 
 
To establish the chorionicity, fetal ultrasound can be performed at seven-nine weeks 
gestation. An observation of two placental masses and the lambda sign indicate dichorionic 
twins. The lambda sign is a triangular extension of the chorionic villi between the two layers 
of twin membrane, and was first described by Bessis and Papiernick in 1981.  
Monochorionic twins have a T sign where the membrane divides the amniotic space and 
reaches the placenta at a 90ºangle (Alhamdan et al 2009). 
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1.4.2. Aetiology 
 
Dizygotic twins are associated with increased maternal age, parity, inheritance and high 
levels of follicle-Stimulating Hormone (FSH). Chromosome 3 has been indicated as the gene 
responsible, showing patterns of autosomal recessive and dominant inheritance, however the 
exact nature of the genetic mechanism is still yet to be fully understood. There has been links 
to the autosomal recessive gene being inherited along the maternal line of the family allowing 
the woman to produce two eggs. It has also been noted that the male needs to have high 
numbers of high quality sperm.  
 
 The use of In Vitro fertilisation (IVF) is associated with higher rates of dizygotic twins as a 
result of the implantation of two genetically different zygotes. 30-50% of twin pregnancies 
are associated with Assisted Reproductive Technology (ART), and over 75% of higher order 
pregnancies are due to ART (Verberg et al 2007).
 
 
1.4.3  Epidemiology 
 
Over the last hundred years there has been a change in the pattern of twinning. Data from 
Sweden and Finland has showed a decrease from the 1930s to the 1950s and in Europe the 
incidence of twins reached an all time low in the 1970s: England and Wales 9.6 per 1000, 
France 9 per 1000. Over the next 20 years there was an increase of over 60% to 13.9 per 1000 
in England and Wales, 14.4 per 1000 in France. In the USA there was an increase of 58% 
from 1972 to 1998. This dramatic increase is likely to be a result of the increased use of ART 
and lack of regulation in the USA where the number of embryos transferred to the uterus is 
based on an individual‟s situation and recommended guidelines rather than statutory law 
(ASRM 2009), hence the more dramatic increase in high order pregnancies (three or more) of 
696%, compared to other countries such as France with 310%, and  430% in England and 
Wales in 1998 (Blondel et al 2002). In 2008 in the UK, there was 10,334 sets of twins born in 
the UK, while only 137 higher order pregnancies occurred (ONS 2008). 
 
Multiple pregnancies have been on the rise as a result of ART. ART places two or more 
fertilized eggs into the uterus, assisting the chances of a zygote implanting and ultimately the 
birth of a fetus. Another technique is to give the mother hormones in order to cause multiple 
follicles to develop improving the chances of a ovum being released and increasing the 
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number available for removal in order to perform In Vitro Fertilisation( IVF).  IVF is when 
conception occurs outside the uterus and an embryo is placed back in the uterus (Verberg et 
al 2007). In the UK 75.8% of IVF pregnancies resulted in singleton deliveries compared to 
23.9%  resulting in twins, but it is important to note that UK Law only allows the 
implantation of two embryos (Anderson et al 2008). 
 
Despite this rise being mostly attributed to the increased use of ART, maternal age also plays 
a strong role, see Table 1.1 for age specific multiple birth rates for England and Wales and 
Table 1.2 for age specific multiple birth rates for the USA. 
 
 
Year All Ages Under 20 20-24 25-29 30-34 35-39 40-44 45 and over 
1998 14.4 6.3 9.5 12.8 17.9 21.0 19.7 56.7 
2008 15.5 6.0 9.7 13.2 17.7 23.7 23.1 93.1 
 
Table 1.1  Multiple Births per 1000 all maternities England and Wales (ONS 2008). 
 
 
Year All Ages 15-19 20-24 25-29 30-34 35-39 40-44 45-54 
2006 33.7 16.5 23.2 31.5 42.6 51.9 58.8 212.1 
 
 
Table 1.2: Multiple Births per 1000 all maternities USA (Martin et al 2009). 
 
In the USA 65% of multiple births with a maternal age of 45 or over was due to ART, 36.3% 
for ages 40-44 and 22.3% for ages 35-39 and only 16% for 30-34. However for triplets with 
maternal ages 35-49 the majority were from ART. However maternal ages from 20-30 had at 
least 30% unexplained triplets. It is important to note that this study used natural conception 
rates from 1972 to indirectly apply age specific multiple birth rates for each cohort, in the 
assumption these figures were accurate for spontaneous conception as it was before the use of 
ART (Reynolds et al 2003). 30% of twin pregnancies are monozygotic, 25% of monozygotic 
twins are dichorionic (Alhamden et al 2009). 5% of all preterm birth are dichorionic, and 
10% are monochorionic (Siddiqui, Fekrat 2005). 
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1.4.5 Maternal Complications 
 
Twin pregnancies are associated with higher rates of nausea and vomiting affecting over half 
of all women with multiple pregnancies. Women with multiple pregnancies are also more 
likely to suffer „minor ailments‟ of pregnancy such as heartburn, fatigue, constipation and a 
higher frequency of micturition due to compression on the bladder from the uterus, and a 
raised abdominal pressure adding to the discomfort of an already demanding pregnancy.  
 
Gestational hypertension has a relative risk of 2.04 (95% CI 1.6-2.6) in twin pregnancies 
compared to singleton pregnancies. A similar pattern is seen in pre-eclampsia with a relative 
risk of 2.62 (95% CI 2.0-3.4). Risk of acute fatty liver also increases-a rare disease but often 
lethal disease that affects the mother in the third trimester and which can progress to renal 
failure and hypoglycaemia, requiring immediate delivery (Rao et al 2004). Placenta praevia is 
more common in twins: 3.9 per 1000 compared to 2.8 per 1000 singletons (Siddiqui and 
Fekrat 2005). 
 
1.4.6 Fetal complications 
 
Twins are associated with higher rates of miscarriage, fetal loss, intra uterine growth 
restriction and preterm delivery. In general all types of twins have a tenfold risk of being 
small for gestational age, and the average length of gestation is 35 weeks compared to that of 
singletons whose average length is 39 weeks gestation (Rao et al 2004). 
 
1.4.6.1 Fetal mortality  
 
Multiple births are associated with higher rates of perinatal mortality and stillbirth rates.  In 
2000 the stillbirth ( a fetus born with no signs of life after 24 weeks) rate was 17.7 per 1000 
for twins and 28.4 per 1000 for high order births, compared to the singleton rates of 5 per 
1000, which in 2003 rose to 5.3 for singletons, 19.6 for twins and 60.9 for high order births 
declining to 4.9, 12.2 and 20.5 in 2006 (CEMACH 2006). 
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1.4.6.2 Prematurity in twins 
 
Twin pregnancies are associated with higher rates of preterm delivery with rates in Canada of 
50.2%, USA  53.7 %  and France 43.7 % before 37 weeks from 1995-1997, compared to 
singletons who had a preterm rate of 5.9%, 9.8% and 4.6% respectively (Blondel 2002), with 
another study finding 8.4% of twins were small for their gestational age (Joseph et al 2001). 
 
Despite advances in treatment for preterm births such as the introduction of steroids, 
surfactant, and the use of incubators, there are still very severe complications associated with 
preterm birth. For instance there is an increased risk of intraventricular haemorrhage, 
periventricular haemorrhagic infarction and periventricular leucomalacia with the risk 
increasing the earlier the gestational age, and these can lead to neurodevelopmental problems 
including cerebral palsy (Lissauer et al 2008). 
 
Twins with a birth weight over 2500g have a greater incidence of cerebral palsy than in 
singletons, 3.9% compared to 1.9%, however no significant difference  was found when the 
birthweight was under 2500g in singleton and twins. However the incidence of cerebral palsy 
was over 69% for both groups (Pharoah 2002). 
 
Due to the inadequate development of the lung, preterm neonates can suffer from severe 
respiratory problems such as respiratory distress syndrome where there is a deficiency in the 
production of surfactant, and infections that can lead to long term respiratory complications 
in childhood and early adolescence. 
 
Another concern for preterm neonates is the development of necrotising enterocolitis where 
bacterial invasion of the superficial mucosa of the gastrointestinal lining cause intramural 
gas, leading to small bowel syndrome. The incidence of necrotising enterocolitis increases as 
the birth weight and gestational age decrease, with a rate of 1 in 100 in preterm infants.  
 
Despite the advances in treatment for preterm infants the most effective environment is the 
uterus and ideally the neonate delivered at term, current guidelines from the Royal College of 
Obstetricians and Gynaecologists recommended the use of Atosiban or Nifedipine however it 
is not recommended to use as maintenance of pregnancy rather than a 24 hour delay in order 
to allow the completion of action by corticosteroids to aid lung maturation as preterm infants 
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have immature alveoli and resultant low levels of surfactant. Surfactant prevents alveoli 
collapse and corticosteroids reduced the risk of  intraventricular haemorrhage by the 
vasoconstriction of cerebral blood flow. However if there is hypercapnea vasodilation will 
occur (Roberts, Dalziel 2006). 
 
The lack of guidelines for preterm labor stems from the lack of knowledge about what 
mechanism directly causes the initiation of labor. However more recent trials have found 
progesterone to be effective in reducing the reoccurrence of preterm delivery and morbidity 
in high risk singletons with a history of preterm delivery (Meis et al 2003). Trials in twins 
and triplets have since been carried out, however progesterone has been found to be 
ineffective at reducing preterm birth (Norman et al 2009, Briery et al 2009, Caritis et al 
2009). 
 
1.4.6.3 Fetal growth discordancy  
 
Growth discordance is when there is a difference between the birth weight of the two fetuses. 
This can be classified as mild <15%, moderate 15-30%, or severe >30%. This can occur due 
to a variety of reasons such as a small placenta, placental dysfunction, fetal sex differences, 
and chromosomal abnormalities (Siddiqui, Fekrat 2005).  
 
1.4.6.4.Twin specific complications  
 
Monochorionic twin pregnancies have unique complications. Twin-to-twin Transfusion 
Syndrome (TTTS) occurs as result of an imbalance of placental blood flow from one twin 
(donor) to the other (recipient). This imbalance occurs as there are various types of 
anatomises on the placenta, some that allow the blood to flow in both directions, and others 
that restrict the blood flow to only one direction. For example arterio-venous (AV) and veno-
arterial anatomises only allow blood to flow in one direction, so if there is higher number of 
AV anatomises TTTS occurs. This usually occurs between 15 and 26 weeks gestation, and is 
made up of 5 stages, which is detailed in table 1.3 (El Kateb, Ville 2008). 
  
 
 
. 
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Stage I The bladder of the donor is still visible 
Stage II Bladder not visualised for 1 hour, Normal Doppler 
Stage III Doppler abnormalities in either fetus 
Stage IV Hydrops 
Stage V Demise in one or both twins 
 
Table 1.3. Stages of twin to twin transfusion syndrome (El Kateb, Ville 2008) 
 
TTTS is diagnosed on ultrasound by the presence of polyhydramnios in one sac with a 
deepest vertical pool of amniotic fluid (DVPAF)  of at least 8 cm after 20 weeks, with 
oligohydramnios present in the other „donor‟ twin‟s sac with a 2 cm DVPAF score. It is 
usually treated with laser therapy ablation. 
 
Monozygotic twins are also at risk of Twin Reversed Arterial Perfusion sequence (TRAP) 
where one twin fails to develop normally and has an absent head, and upper limb structures 
as well as being acardiac. This occurs in 1% of pregnancies and is treated with diathermy to 
prevent blood going to the acardiac twin (Duncan 2004). 
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1.5  The effect of stretch on the uterus and protein expression 
 
The uterus increases in size and weight as result of hypertrophy and hyperplasia due to the 
mechanical stretch applied by the growing fetus. This enhances the expression of the gap 
junction protein connexin 43, as well increasing the production of prostaglandins before 
labour (Salameh et al 2010). It was also found that COX-2 activity was increased when 
exposed to mechanical stress, and had greater activity in myometrium taken from labouring 
samples (Sooranna 2004). 
 
Stretch and inflammation are both potential triggers for labour through IL-8, which is 
associated with infection-induced labor. Stretch indirectly affects IL-8 through the MAPK 
pathway, with mechanical stretch activating all three types of MAPK (Sooranna 2005). 
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1.6 Aims 
 
Multiple pregnancies are associated with higher rates of morbidity and mortality compared 
with singletons, and a significant contributor to this is preterm labour and delivery. Currently 
there is no gold standard treatment for the prevention of preterm delivery and the 
pathophysiology is still not fully understood.   
 
The first aim was to examine the difference in myometrial properties of multiple and 
singleton pregnancies, building on previous work in the laboratory. 
 
The second aim was to explore the effects of progesterone and to examine if there is a dose 
response relationship, and to test the hypothesis that progesterone differs in its effect in 
multiple and singleton pregnancy myometrium. As progesterone plays a role in uterine 
quiescence, it has been used in various clinical trials for the prevention of preterm delivery 
(before 37 weeks) to be effective in high risk singleton pregnancies (Meiss et al 2003), but 
not in multiple pregnancies (Norman et al 2009, Briery et al 2009, Caritis et al 2009). 
 
The third aim of this study was to examine the effect of stretch on progesterone response. 
Increased stretch could be the underlying reason why there is a reduced response to 
progesterone in twin pregnancies. 
 
The final aim of this study is to review current dietary advice for multiple pregnancies as 
there is much debate and some advocate specific calorific intake and diet components in an 
attempt to reduce complications including preterm delivery.  Currently there are no 
guidelines on nutrition for multiple pregnancies with some advocating a diet of over 3000 
calories a day (Luke et al 2003) to a more conservative approach, and it is important to take 
into consideration the need of the mother as well as the fetus as obesity is associated with 
long term health complications. 
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Chapter 2: Methods 
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2.1 Abstract 
 
This chapter will discuss the general methods and solutions used. It will describe how 
consent was gained, the dissection process used and how the experiment was performed. It 
will also explain what computer software was used and what was done to reduce bias.  
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2.2 Introduction 
 
All experiments used human uterine tissue obtained from consenting women, having 
previously had the ethics approved by the national ethics committee.  The anonymity of the 
patient was maintained by samples being collected and identified by a reference number only. 
Samples were allocated a unique reference number as part of the Myometrial Research Tissue 
Bank e.g. M00100. The Myometrial Research Tissue Bank is maintained and regulated at the 
Liverpool Women‟s Hospital, and all consent forms and proformas are securely kept there. 
Singleton samples were kindly consented for by the Research Midwives at the Liverpool 
Women‟s Hospital in pre-operative clinic. Multiple births samples were consented by the 
author or Doctors in the Multiple Birth Clinic at the Liverpool Women‟s Hospital. 
 
2.3 Consent 
 
When women were asked for consent they were given the following information: 
 The Myometrial Research Tissue Bank collects and stores tissue taken at caesarean 
section. 
 The surgeon will removed a small piece of tissue approx 2 x4cm after removing their 
baby(s) 
 They will not have long term effects as a result of the biopsy, and previous experience 
has found that it will not delay healing or increase the risk of bleeding. 
 Some pieces are used to study muscle contraction, or frozen or used to investigate 
other factors including ribonucleic acid (RNA). 
 All women are allowed to change their mind at any time even after the sample has 
been taken and stored. 
 There will be no financial rewards for the patient or the Research Tissue Bank 
 Medical records that relate to the pregnancy/labour will be periodically examined  
 Any information used will be treated securely and confidentially  
If they were happy to consent then a carbon paper form was signed and dated. One copy 
was given to the patient, one to the research tissue back and one copy would be attached 
to the patient‟s hospital notes.  
The majority of women were consented for an elective caesarean section as a result of 
breech presentation in twin one or in singleton pregnancy, medical advice if they had had 
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a previous caesaraen section. Samples obtained from Emergency Caesarean Section were 
due to fetal distress . Figure 2.1 shows the method of sample collection and what path 
samples followed e.g collection or loss of samples due to unexpected early emergency 
caesarean sections. 
When consent was obtained a proforma was used to collect the patient details that were 
stored at the research bank at the Liverpool Women‟s Hospital. 
 
2.2.2 Collection of tissue biopsy 
 
The myometrial biopsies were removed post delivery of infant(s).  When a sample was 
collected it was placed into Hank‟s Buffered solution in a 130ml sample pot, labelled 
with the unique identification sample number and the date is was taken. 
It was then placed in a fridge at 5
º
C or 4
º
C
 
and then transferred to the Physiological 
Laboratory.  This occurred within 0 – 8 hours in 80% of the samples. 
Once transferred to the laboratory the tissue was finely dissected using a light microscope 
(Nikon, UK). Each strip was dissected into 5 mm x 5 mm x 3mm. Once dissected metal 
foil clips would be attached to each end, and one end attached to a fixed point and the 
other to a force transducer. The force transducer was connected to a computer via an 
amplification box and recorded using the programme Axoscope version 8.0. See Figure 
2.2 for an overview of biopsy method. The force was measured isometrically, by having 
resting tension on the strip so that when it spontaneously contracted it would „pull‟ on the 
transducers.  
 
The solution used to superfuse the tissue in a perfusion bath, was a physiological saline 
solution and the temperature was 37
º
C, and pH 7.4. 
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Figure 2.1. A flow chart showing how patients were recruited and potential outcomes 
Sample 
forgotten 
Sample   
obtained 
Sample not 
obtained, either 
due to not being 
approached or 
sample not 
taken 
Sample 
obtained 
Sample too 
small 
Sample correct size and 
used for experiments 
Patient 
declined 
Women with multiple pregnancies were approached for the study who 
were confirmed to have an elective caesarean section at 37 weeks, based 
on clinical information: Twin 1 Breech, medical advice as had had a 
previous caesarean section. This was decided at 32 weeks gestation. 
Women with multiple pregnancies, who were admitted to the delivery 
suite and required an emergency caesarean due to fetal distress, were 
approached after having been consented for caesarean section by the 
Doctors present. 
Women with singleton pregnancies who were attending pre-operative 
clinic prior to elective caesarean section were approached for the study, 
were consented by Research Midwives attending the clinic  
 
 
 
 
Spontaneous labor Elective Caesarean 
Section. 
Emergency 
Caesarean 
Section 
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Figure 2.2 Overview of biopsy method (Kindly donated by S Arrowsmith.) 
 
 
 
2.3 Solutions 
 
All chemical were from Sigma (Dorset, UK), and were handled using the required safety 
precautions in the laboratory. 
 
2.3.1 Physiological saline solution 
 
Physiological saline solution was used to superfuse the sample, and the pH was adjusted to 
7.4 using alkali or acid e.g. Na OH, HCL.  The solutions were buffered with 4-(2-
Hydroxyethyl) piperazine-1-ethanesulphonic acid (HEPES), and made up in double distilled 
water. See Table 2.1 for composition of the physiological saline solution.  
All solutions were mixed using a magnetic stirrer. 
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Substance  Amount measured 
to make 1l(g) 
Molarity(mmol) 
Sodium chloride 154 8.99 153.90 
Potassium chloride 5.4 0.40 5.36 
Magnesium sulphate 1.2 0.29 2.40 
HEPES 11.0 2.62 10.99 
Glucose 8.0 1.44 7.90 
Calcium Chloride 110.98 2.00(ml) 2.00 
 
Table 2.1 Physiological saline solution 
 
The calcium chloride was added prior to adjustment of pH. 
 
A high K
+ 
 ion solution of 40 mM potassium chloride was used to produce a maximal force 
contraction. This was made by adjusting the sodium chloride and potassium chloride 
quantities in a 1L solution to 6.99 g Sodium Chloride, and 2.98g potassium chloride. This 
was added for 2 minutes in order to elicit maximal force from the preparation, to enable 
standardization of results between samples. 
 
Progesterone 
 
A stock solution of progesterone was made using 70% ethanol to make a 10 mM 
progesterone. This was used to make the three concentrations of progesterone used: 1μM, 
10μM, and 100μM. 100ml of 100μM progesterone was made using 100μl of the stock 
solution into 100ml of physiological saline solution. In order to minimise the amount of 
ethanol used the 100ml solution of 100μM progesterone was used to make the 10μM by 
adding 10ml of this solution to 90ml of Krebs. The 1μM progesterone was made adding 10ml 
of the 10μM progesterone solution to 90ml of Krebs solution. The stock solution was made 
by adding 0.3g of progesterone to 7ml of ethanol and once this had dissolved adding 3ml of 
diluted water.  
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2.3.3 Vehicle control solution 
 
In order to confirm that any effect found was due to the progesterone rather than the 70% 
ethanol, a control solution was made using the strongest concentration of ethanol used. As the 
highest concentration of progesterone was 100μM, the dilution of from this concentration 
was tested. A solution of 1 in 1000 dilution of 70% ethanol was made adding 100μl of 70% 
ethanol to 100ml of physiological salt solution.  
 
 
2.4 Force measurements 
 
The contractions of the muscle strips were recorded by a tension transducer that was 
calibrated so that 1mN equalled a 1mV deflection, as shown by the Axoscope software. This 
was done by placing a 1mN weight on the transducer and by adjusting the amplification box 
appropriately.  
Before the strip was clipped on using the foil metal clips, physiological saline solution was 
run continuously through for ten minutes in order to allow the heat resistor to have reached 
the appropriate temperature for the strip. Once the strip was attached it would be then 
stretched by 1.5mN which equated to 1.5mV by using the baseline on the axoscope 
programme. 
The strip was then left until spontaneous contractions occurred. Once contractions had started 
no solutions or stretch were added until there was a regular control period. The next chapters 
will give more details about the specific experiments.  
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Chapter 3: The contractile properties of 
multiple pregnancy and singleton 
myometrium. 
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3.1 Abstract 
 
Multiple pregnancies are associated with higher rates of preterm delivery than singleton 
pregnancies, however the direct cause for is unknown. Studying the difference between the 
properties of multiple birth and singleton myometrium will enable us to further our 
understanding as to why over 50% of twins deliver preterm. 
Previous work has shown that twins have a higher mean weekly frequency uterine 
contractions using home monitoring systems (Hernandez et al 2008). Work in vitro has also 
shown that there was a significant longer duration (Turton et al 2008). 
Biopsies were obtained for triplet, twin and singleton myometrium, and were then dissected. 
The biopsies were placed in a physiological salt solution perfusion bath, and were left until 
spontaneous contractions occurred.  
There were no significant differences between the triplets, twins, and singletons for force, 
intercontraction interval, duration, and force integral.  
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3.2 Introduction 
Multiple pregnancies are associated with higher rates of preterm delivery and perinatal 
mortality than singletons, as a consequence of the uterus containing two or more fetuses. 
However the direct link as to why multiple fetuses cause preterm delivery is unknown. In 
order to obtain a greater understanding, it is necessary to take into consideration how the 
multiple pregnancy uterus differs in its properties to a singleton uterus. 
Work by Hernandez et al using daily uterine monitoring found that preterm twin pregnancies 
had a higher level of uterine activity in the third trimester compared to twin pregnancies that 
reached term. (Hernandez et al 2008) Uterine contraction frequency in singletons is also 
increased prior to preterm labor, but not in triplets (Newman et al1989). 
In the twin uterus it has also been found to have a significantly higher mean weekly 
frequency of uterine contractions than singleton pregnancies, increasing each week prior to 
labor (Newman et al 1986). 
There has only been one study of the in vitro characteristics of twin and singleton 
myometrium. This also reported differences.  The amplitudes of force were similar between 
groups but it was also observed that there was a higher frequency of contractions in twins, 
and contractions were significantly longer in duration (Turton et al 2008). 
This chapter will continue to investigate the different myometrial properties measuring the 
force amplitude, average intercontraction interval, average duration, and the force integral 
(area under the curve). 
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3.3 Methods 
 
All patient samples were collected as stated in chapter two, and were consented before 
caesarean section took place. The sample was taken after delivery of the fetus(s). Once the 
sample was taken it was anonymized, and given a unique reference number.  
Samples were collected from the Liverpool Women‟s Hospital, and placed in Hank‟s 
Solution. During dissection they were placed in a physiological Krebs salt solution with pH 
7.4, which was used throughout the control experiments.  
 
3.3.1 Contractile Experiments 
Once samples were obtained and dissected into small strips of 10mm x 2 mm x2mm, foil 
metal clips were placed on both ends. The metal clips were placed on a force transducer, 
submerged in a water bath of Krebs at temperature 37ºC, with 1.5mN of stretch applied. The 
strips were left until spontaneous contractions occurred. A minimum of 4 contractions that 
were regular in force and intercontractile interval were used for analysis. This was recorded 
using Axoscope, and analysed using Origin 8 (supplied by the University of Liverpool). 
3.3.2 Measurements 
Using Origin pro 8 the force, intercontraction interval, duration and area under the curve 
(AUC) was calculated for each sample.  
Force was measured by calculating the amplitude of the contraction, then using the average 
contraction in this control period. The amplitude was calculated by subtracting the y value at 
the base of the contraction from the y value at the peak of the contraction. See figure 3.1 
Intercontractile interval was measured using the x value from the base of each contraction 
then subtracting it from the previous x value see figure 3.2 Due to the variability of samples., 
it was decided to record the time taken for each contraction rather than a selected time period. 
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Figure 3.1 Measuring Force  
The force amplitude was calculated subtracting the base y value from the peak y value. 
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Figure 3.2 Measuring intercontraction interval 
ABCD are the x values at the base of each contraction. The intercontraction interval was 
calculated by subtracting C from D, C-B, B-A. The average intercontraction interval was then 
calculated by adding the sum of these values then dividing by three.  
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The duration of the contraction was calculated at the midpoint of the force amplitude i.e. at 
half height. From this value the x value was noted for the period of contraction and 
relaxation, see figure 3.3. 
 
 
 
 
 
 
Figure 3.3 Measuring Duration  
 
 
The midpoint of the force is used to calculate the duration by using the two x values that 
cross this point, and then calculating the difference. The average was then calculated from 
three contractions.  
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Area under the curve is the measurement of the mean force integral. This was calculated 
using the last twenty minutes of the control period, and using origin to give the area under the 
curve value.  See Figure 3.4 
 
 
 
 
Figure 3.4. Calculating area under the curve  
Using Origin 8.0 the area under the curve (as indicated by the blue above) was calculated for 
a ten minute period.  
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3.4 Results 
 
3.4.1 Baseline characteristics 
 
19 singleton, 10 twin and 2 triplet samples were obtained. 2 singleton samples were 31 and 
33 weeks gestation and were a twin sample with a gestation of 27 weeks were also excluded. 
Due to the small n number of triplets they were also excluded from analysis. Table 3.1 shows 
the general characteristics of the two different groups. See Appendix A for full details of 
patient information. 
 
Table 3.1 Characteristics of the groups 
 
 Twin 
(n=9) 
Singleton 
(n=17) 
Median Gestation 37(37-37+4)) 39+1(39+1-39+1) 
Mean Maternal 
Age 
33±1 30±2 
Median Parity 1(0-1) 1(1-2) 
 Median Gravida 2(1-3) 2(2-3) 
 Mean BMI 23.2±1.5 25.4±1.4 
 
 
*P=<0.05 Mann-Whitney Test 
 
Using the Shapiro-Wilk W test to establish normal distribution it was found that the 
gestation, parity, and gravid were not normally distributed, and therefore  the Mann Whitney 
Test was used to test for significance.  
The gestation of each group was significantly different however all other factors were not 
significant. All data was obtained from elective caesarean sections due to a breech 
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presentation (Twin 1 breech) or a previous history of caesarean section. The emergency 
sections were the preterm samples that were not included in analysis.  
 
 
Figure 3.5 Singleton myometrium contractile trace in a physiological salt solution 
Figure 3.6 Twin myometrium contractile trace in a physiological salt solution 
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3.4.2 Force Amplitude 
 
There was no significant difference between force amplitudes for each group; Twins 
(5.3±2.4), Singletons (4.9 ±1.2). See figure 3.7. 
 
 
 
Figure 3.7. Mean force amplitude of twins and singletons. 
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3.4.3 Intercontraction interval 
 
The mean intercontraction interval for twins, and singletons was not significant when p≤0.05, 
Twins 7.7±1.1mins, Singletons 8.7±3.6mins. See figure 3.8. 
 
 
 
 
 
 
Figure 3.8. Intercontraction interval. 
Although the singleton intercontraction interval was higher, it was not significantly different. 
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3.4.4 Duration 
 
The average mean duration of contractions twins and singletons was 1.12±0.36, 
0.73±0.05mins respectively. The twin samples had a longer duration out of all groups 
however this was not significant.  
 
 
 
 
  
 
 
Figure 3.9 Mean duration. 
The mean duration was longer in the twin duration than the singletons, however no 
significance was found.  
 
 
 
Duration 
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3.4.5 Force Integral (Area under the Curve) 
 
The average force integral was higher in both twins and singletons 17.6±8, and 18.8 ±3.5.  
See figure 3.10. 
 
 
 
 
 
 
Figure 3.10 Mean force integral (mN/10mins). 
The force integral was higher in the twin myometrium, however this was not significant. 
 
 
 
 
 
Mean Force 
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47 
 
3.4.6 Triplets 
 
With the two triplet samples, the mean maternal age was 33, average gestation was 32 weeks, 
G2, P3 and mean BMI was 24.5. However at 32 weeks triplets pregnancies have a caesarean 
section so this is not a true gestational age.  
Mean Force was 5.39±4.8, Intercontractile interval 7.6±0.5 mins, duration 0.76±0.02, and 
area under the curve 11.6±9.  
 
3.4.7 Preterm singletons 
 
Preterm singletons had a mean maternal age of 20, gestation 31 weeks, G2, P1, and BMI 31.  
Mean force was 10.3±0.9, intercontractile interval 3.86±2.7 mins, mean duration 0.42±0.1, 
and mean area under the curve 28±3.3. In comparison to the term singletons, the force is 
twice as high with contractions twice as common, and of shorter duration, and larger area 
under the curve. However as n=2 it is difficult to confirm significance.  
 
3.4.8 Preterm twin 
 
Maternal age was 29, gestation 27 weeks, G1, P0, and BMI was 26.2. Force was 0.88, 
intercontractile interval was 8.7, duration 0.65 and area under the curve was 4.44. Preterm 
twins had a lower force, higher intercontractile interval, shorter duration, and smaller area 
under the curve. It should be noted that only one preterm sample was collected.  
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3.5 Discussion 
 
Earlier work has demonstrated that twin pregnancies have a higher contraction frequency 
than high risk singletons at term. In vitro evidence showed that duration was significantly 
longer in twins, as well as observing a higher frequency (Turton et al 2008). 
 
A comparison of the three groups showed no significant differences in force amplitude, and 
force integral.  
Twin pregnancies showed a longer duration than triplets and singletons however no 
significance was shown, contrasting with previous work in vivo that had larger sample 
numbers. On comparison between the preterm samples and the term samples the preterm 
singleton samples have a much higher force and Intercontractile interval, a shorter duration, 
and a much higher force integral, nearly 10 mN/10mins higher. Yet it should be noted there is 
a much smaller n number for this group of preterm singletons, and it was not significant.  
 
The comparison of the preterm twin and term twins showed that the intercontractile interval 
was similar, but there was a greater force, and longer duration in the term twin. It should be 
noted that there was only one preterm twin, as there are many limitations obtaining a preterm 
twin, as will be discussed in the limitations and future work.  
 
As the myometrial properties of all groups are not statistically significant, it may be likely 
that other factor plays a greater role in stimulating preterm delivery in multiple births, rather 
than an inherent property of the myometrium. It may be either hormonal factors triggering the 
myometrium or an inflammatory process.  However as noted below, my twin numbers were 
not large and this, coupled with inherent variation between women, may have made it 
difficult to reveal differences in the parameters of force, if they are not large.  Previous in 
vitro work that used the same methods as noted in this chapter did find significant longer 
durations in twins and observed a higher frequency. However they did have a greater sample 
size of eighteen compared to a sample size of nine (Turton et al 2008). 
 
 
 
 
 
49 
 
 
3.6 Limitations and Future Work 
 
One of the main problems was obtaining the samples, despite twins and singletons mothers 
being consented. There were issues with remembering to take the sample, as theatres are busy 
places, and the care of the women is the priority of the doctor. For example if twin one was 
breech then the mother would be booked for a caesarean at thirty seven weeks, however that 
did not prevent the twins from delivering early, out of hours or prevent complications. As 
some of the twins did require emergency caesarean sections out of hours, it was 
understandable that the sample was forgotten. This reduced the total number of twins 
available. This is was also a problem with obtaining preterm twins as the majority would be 
via a vaginal birth and would have no need for caesarean section. 
 
Another limitation is the dissection process itself, although the dissection skills improved 
over the year however it was a new skill that needed to be learnt, and this would limit the 
quality of the traces. There were also inherent variations between biopsies. 
For future work it would be important to increase the total number of triplets as this was also 
a limiting factor. And to find a way to encourage doctors to remember to take a sample, as 
through the year this did improve yet it was still an issue. 
 
3.7 Conclusion 
 
Twins had a longer duration than both groups, however this was not significant. There were 
no significant differences between the force, intercontractile interval, duration and force 
integral.  
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Chapter 4: The effect of progesterone on 
twin and singleton myometrial contractility 
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4.1 Abstract  
 
Early in pregnancy progesterone plays a role in implantation, and later is responsible for 
uterine quiescence. Previous work in vitro has found it to be effective in inhibiting uterine 
contractions (Anderson et al 2008). In high risk singleton pregnancy studies, it was found to 
be it effective in preventing preterm birth in women who had a history of preterm labor (Meis 
et al 2003). However similar results were not seen in multiple births;  it was found to be 
ineffective in preventing preterm delivery (Norman et al 2009, Briery et al 2009, Caritis et al 
2009). 
 
One of the reasons for this difference could be due to a higher dose being required in twin 
pregnancies. The efficacy of progesterone in twin myometrium studied in vitro is unknown.  
To test these myometrial biopsies were obtained from ten twins and sixteen singletons 
pregnancies during caesarean section, and dissected. A control period was established, and 
then 1, 10,100 am progesterone solutions were added, and the force, intercontractile interval, 
duration and force integral were measured. 
 
Progesterone displayed a dose response relationship in singleton and twin myometrium 
inhibiting uterine contractions. At 10 and 100μM progesterone there was a significant 
difference in response to progesterone, showing that progesterone was more effective in 
inhibiting singleton myometrium than twin myometrium.  
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4.2 Introduction 
 
Progesterone has long been established to play a role in maintaining uterine quiescence. In 
small mammals it has been found that labor is preceded by a fall in progesterone, however in 
humans progesterone levels keep rising (Astle et al 2003). It has been hypothesised that this 
may be due to a change in genomic progesterone receptors (PR), which has two isoforms 
PRA and PRB, and a change in the ratio of PRA/PRB is responsible for the more active 
uterus (Zakar 2007). However more information is coming to light that shows progesterone 
also works non genomically, via plasma membrane receptors that are similar in structure to 
G-protein coupled receptors (Fernandez et al 2008). When this receptor is activated it causes 
an increase in cyclic adenosine monophosphate (cAMP) by inhibiting the enzyme responsible 
for its hydrolysis, as discussed in greater detail in Chapter one (Gellersen et al 2009). 
 
 Much in vitro work has found that progesterone is able to inhibit uterine contractility 
(Anderson et al 2009) although its synthetic form 17-alpha hydroxy-progesterone may be 
ineffective (Ruddock et al 2008).  
In several studies it was found to be effective in the use of preventing preterm delivery in 
high risk singleton pregnancies, where there was a history of preterm delivery (Meis et al 
2003). Despite its success with high risk singletons however studies that used twins and 
triplets were not as successful, finding that it did not prevent preterm delivery (Norman et al 
2009, Caritis et al 2009, Briery et al 2009).  
 
 In vitro progesterone is effective in inhibiting spontaneous human uterine contractions in a 
dose dependent manner (Ruddock et al 2008). This led to the hypothesis that progesterone 
differs in effect in twin and singleton myometrium, specifically it is less effective in twins 
and its dose response curve is shifted to the right. 
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4.3 Method 
 
Nine twins, sixteen singletons, two triplets, two preterm singletons were used for analysis.  
Patient recruitment and consent was obtained as discussed in chapter two at the Liverpool 
Women‟s Hospital. Once samples were obtained they were placed in a Hanks salt solution, 
and dissected into small strips of 2mm x 2mm x 10mm and placed onto a force transducer 
with metal foil clips.  
 
4.3.1 Progesterone Protocol 
 
Once a suitable control period was established with a minimum of four contractions with 
similar force and intercontractile interval, 1μM progesterone was added for the next four 
contractions, then 10μM progesterone for four contractions, followed by 100μM progesterone 
for four contractions. Chapter two contains information about how these solutions were made 
using ethanol as the vehicle for progesterone.  
 
Each period of different concentrations was used for analysis with Origin8. For each period 
the force, intercontractile interval, duration and force integral were measured as discussed in 
Chapter three to compare the effect of progesterone between multiple pregnancies and 
singleton myometrium, the percentage of the original control force was calculated for 1μM, 
10μM and 100μM by dividing the progesterone force amplitude by the control force, and then 
multiplied by one hundred.  
 
Control strips were also placed in vehicle only solutions to ascertain if any effect was due to 
the ethanol rather than the progesterone. Experiments were also made using only 1μM or 
10μΜ progesterone, to see if the response made was due to an accumulation of progesterone 
rather than due to a higher concentration of solution. 
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4.4 Results 
Progesterone had a dose dependent response in both twins and singletons, however this 
response was reduced in twins, see figure 4.1 and 4.2 illustrating progesterone‟s effect on 
myometrial contractility in twins and singletons.  
 
Figure 4.1 the effect of progesterone in singleton myometrium 
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Figure 4.2 The effect of progesterone in twin myometrium 
4.4.1. Force Amplitude  
 
At 1μM, progesterone reduced the force amplitude in both twin and singleton groups, having 
a greater effect in the singleton myometrium however this was not significant. When the 
percentage of force amplitude was calculated, progesterone reduced the force of the 
contraction in twins to 87±3% and 72±5% in singletons. However at this concentration little 
or no effect was seen in preterm singletons (98±0.4%) and triplets (100 %). 
 
A difference in response between multiples and singletons starts to be seen at 10μM 
progesterone as the force amplitude is reduced with incremental doses of progesterone, and 
the response in singleton myometrium was significantly greater than in twin myometrium, 
reducing the percentage control amplitude to 32±7% while only reducing the percentage of 
control amplitude in twins to 68±4%, p=<0.02. In the triplets the average control force was 
100%, yet in the preterm singletons it was reduced to 72±1%.  
 
When the concentration of progesterone was increased to 100μM progesterone force was 
almost completely abolished in the singleton, reducing the mean force to 0.5±0.2mN and 
mean percentage control force to 7±1.7%.  A significant difference was seen in twins with a 
mean percentage of control force of 31±7%, p=<0.001. Figure 4.3 shows the dose response 
relationship of progesterone in singletons and multiples.  
 
 
% Control 
Force * 
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Figure 4.3 The effect of progesterone in multiples vs singletons * P≤0.05 
                                                                                                                                        * P≤0.05 
 
                                                    Progesterone (μM)   
Figure 4.4 The effect of progesterone on percentage of control force in twin vs singleton 
myometrium 
 
Figure 4.5 The effect of progesterone on percentage of control force in triplet and singleton 
myometrium. 
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Figure 4.6  A dose response curve of progesterone illustrating that a higher dose of 
progesterone is required to reduced the control force to the same degree as in the singleton 
myometrium,  
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4.4.2 Intercontractile interval 
 
At 1μM progesterone there was a decrease in the mean intercontractile interval of 
contractions in twins and singletons from 5.3±1.2 mins, 4.9±2.4 mins to 8±1 and 6.6 ±1, 
showing that progesterone increased the time taken for a contraction to occur.  
 
When the concentration of progesterone was increased to 10μM, the mean intercontractile 
interval decreased to 7.8± 1 mins for twins and 6±1.4 mins for singletons. A similar effect 
was also seen in the preterm singletons and triplets (7±0.3 to 6.2±0.1 mins). 
There was a significant difference between the singletons and twins at a 100m with a greater 
increase in the singleton myometrium to 2±0.1 where as the twin mean intercontractile 
interval was 4.4±0.4. The triplet intercontractile interval was also lower than singleton 
however this was not significant, 4±1.   
 
Progesterone (μM) 
* P≤0.01 
Figure 4.7 The effect of progesterone on intercontractile interval 
 
 
* 
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4.4.3 Duration  
 
At 1μM progesterone there was no change in the duration of contraction in singletons and 
triplets however the mean duration changed to 0.7±0.1mins in twins, yet this was not 
significant.  
When the dose of progesterone increased to 10μM the only change in duration was term 
singleton group to 0.6±0.07mins. However when the dose was increased to 100μM the 
singleton, twin group and the preterm singletons mean durations were decreased to 0.3±0.07 
mins, 0.6±0.1mins,  0.3±0.1mins respectively however the p value >0.05. 
 
 
 
Progesterone (μM) 
 
Figure 4.8 The effect of progesterone on duration 
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4.3.4 Force integral (area under the curve) 
 
In general there was a decline in the force integral as the concentration of progesterone 
increases, however there were no significant differences between the groups.  
 
The greatest decreases occurred at 1μM and 100μM progesterone as can be seen in table 4.1. 
At the 100μM progesterone in triplets and preterm singleton the force integral increases.   
 
Progesterone (μM) 
AUC(mN/10mins) 0 1 10 100 
Triplets 11.6±10 9.6±5.9 8.8±6.1 10.9±5.8 
Twins 17.6±8 15.0±6.6 15.2±7.3 8.0±3.6 
Term Singletons 18.8±3.5 14.3±3.3 15.7±1.6 4.1±1.3 
Preterm 
Singletons 
28±3.3 23.1±7.0 22.6±7.7 23.4±13.5 
  
 
Table 4.1 The effect of progesterone on the area under the curve. 
This table shows that in triplets there is no significant difference between control and 
progesterone groups. However despite the reduction in force integral for singletons and twins, 
there were no significant differences between the groups.  
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4.4.5 Control Experiments 
 
In order to confirm that the change in uterine contractility was a result of an increase in 
progesterone rather than an accumulation of the vehicle (70% ethanol), control strips were 
used with 1 in 1000 dilution, as this was the strongest concentration of ethanol used. This was 
maintained for two hours, and showed that the  ethanol had no effect. See Figure 4.9 
 
Experiments using only 1μM, 10Μm, or 100μM were used, in order to ascertain if there was 
a dose response relationship or if it was an accumulation of the lower doses.  These strips 
showed that the initial reduction of force was maintained and that the decrease in force was 
due to dose response relationship.  
 
 
 
 
 
 
Figure 4.9 The effect of vehicel on myometrial contractility 
This figure shows that when the vehicle was added, it did not cause a reduction in the force of 
amplitude, and therefore the reduction in force shown in the progesterone experiments was 
due to progesterone rather than the ethanol. 
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4.5 Discussion 
 
Progesterone had a dose-dependent effect on contractions over the range examined, in both 
singleton and twin pregnancy. Significant differences in the dose effects results were found at 
10μM and 100μM progesterone. At lower doses of progesterone there was a reduction in the 
force amplitude, increase in intercontractile interval, shorter duration and decrease in force 
integral however there were no significant difference between the groups.  At higher doses 
10μM and 100μM progesterone, there was a significant difference in reduction of the force 
amplitude that supports the hypothesis that the twin myometrium has a greater resistance to 
progesterone.  
 
This difference could occur as a result of the increased stretch placed on the twin 
myometrium earlier on in the pregnancy, and reduce the expression of the progesterone 
receptor. As progesterone acts rapidly within minutes, it is likely that in vitro it is working via 
the progesterone membrane receptors, which recent work has shown increases the cAMP 
levels. The raised cAMP enhances uterine relaxation (Fu et al 1998). 
 
The intercontractile interval of contraction generally increased as the dose increased. 
However this occurred as the result of the force of the contractions being reduced, and 
therefore the recovery period was shorter allowing a new contraction to occur sooner. This 
was also accompanied by a shorter duration supporting this action rather than the 
progesterone stimulating calcium channels to open. At 100μM there was a significant 
difference between the twin and singleton myometrium, the singleton had a higher 
intercontractile interval than the twin myometrium.  
 
Clinically with progesterone showing greater efficacy in singleton pregnancies, it would be 
useful to consider a higher dose of progesterone for twin pregnancies. Current doses used for 
singleton studies have explored using vaginal pessaries from 90-400mg for singletons. With 
giving a higher dose it may be beneficial to give it vaginally as it has been shown to avoid 
hepatic first pass side effects, which would increase with a higher dose given orally (Tita et al 
2009). 
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Mean serum progesterone in singletons at 16 weeks was 140.2±4.9nmol/L, and rises to 
265.7±9nmol/L at 27 weeks (Lagiou et al 2003). However there is little literature of exact 
levels in twin pregnancies, however it has been reported that as a result of a larger placenta, 
there are increased levels of progesterone in twin pregnancies, with levels at 26 weeks having 
a median level of 688(349-1105) nmol/l in twin pregnancies (Johnson et al 1994). 
With the number of fetuses increasing hormonal levels it is difficult to estimate what 
appropriate dose would be worthwhile, with high circulating plasma levels. 
It is important to question whether or not a higher dose of progesterone for twin pregnancies 
would work. 
 
A progesterone metabolite (5β-dihydroprogesterone) has also been previously found to 
reduce the force, frequency and force integral of singleton uterine contractions, and this could 
also have a role in uterine relaxation (Thornton et al 1999). 
 
4.6 Limitations and further work 
 
The effects of progesterone were so different between twins and singletons that even with 
relatively small n numbers, significant differences were found.  Future work could 
concentrate on the difference between term and preterm twins, and preterm singletons, 
however there is difficulty obtaining these samples as these would likely be obtained from 
emergency sections. Also other progesterone preparations could be examined such as 17-
alpha hydroxyl progesterone to explore the in vitro relationship in twins. Future work could 
also explore the expression of the membrane receptors in multiple births and singletons.  
 
4.6 Conclusion 
 
Progesterone displays a dose response relationship in singletons and twin myometrium. There 
was a significant difference at 10 & 100μM progesterone in the reduction of control force 
amplitude, supporting the hypothesis that progesterone has less of an effect in twins.  
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Chapter 5: The impact of stretch on the 
effect of progesterone 
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5.1 Abstract 
 
Multiple pregnancies increase the amount of hyperplasia and hypertrophy in the uterus, in 
order to accommodate for two or more growing fetuses. 
It is hypothesized that this higher degree of stretch is responsible for the higher of preterm 
deliveries in this particular group. 
 
In the previous chapter it was found that progesterone is less effective in reducing force 
amplitude in twin myometrium than singleton, and that the reason for this could be as a result 
of stretch influencing the progesterone membrane receptor expression.  
 
Therefore in order to explore this relationship paired experiments were performed.  A 
comparison of the effect of progesterone with and without „stretch‟ was made. Although it 
appeared that stretch reduced the effect of progesterone, this was not significant, probably 
due to low sample numbers (n=5). 
More work is required to explore the effect of stretch on progesterone, and its effect on 
human myometrium. 
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5.2 Introduction 
 
It has long been established that multiple pregnancies are associated with higher rates of 
preterm delivery and perinatal mortality than singleton pregnancies (ONS 2009). The direct 
cause of the reason why twins deliver preterm is unknown; however stretch may play a part.  
 
Throughout pregnancy the myometrium undergoes hyperplasia and hypertrophy, and stretch 
increases levels of contraction associated proteins for example connexin 43, cyclo-
oxygenase-2, and oxytocin receptors, as well as interleukin eight mRNA expression (Ou et al 
1997, Salameh et al 2010, Sooranna et al  2004, Sooranna et al  2005, Loudon et al 2004).  In 
multiple births the uterus undergoes greater quantities of stretch in order to accommodate the 
demands of two or more growing fetuses.  
 
All these changes maybe speculated to be increasing or occurring earlier in gestation in 
multiple pregnancies, leading to an increased contractile drive. This may therefore be a cause 
of the increased prematurity in multiple pregnancies in comparison to singleton pregnancies. 
In chapter four it was found that twins had a greater resistance to the tocolytic effects of 
progesterone than singletons. This could be as a result of stretch reducing the expression of 
progesterone receptors; or switching the PR isoforms at an earlier stage in gestation, to the 
forms that are less receptive to progesterone. There is however no literature on the 
relationship between progesterone and stretch. In order to gather further information, I 
undertook preliminary experiments to test the hypothesis that stretch reduces the 
effectiveness of progesterone.  
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5.3Methods 
 
Patient recruitment was performed as described in chapter two, and the myometrium was then 
dissected into strips of 10mm x 2mm x 2mm, and placed on the force transducer.  
 
5.3.1 Stretch protocol 
 
 Two strips from each sample were used as paired data; one with 100μM progesterone, and 
another strip with 100μM progesterone and stretch.  5 term samples were used.  
The „stretch strip‟ was initially set to the same degree of resting tension. Both strips were 
allowed to start spontaneous contractions, and once control activity was established, a 
40mmol potassium solution (High K+) was added which causes the muscle to depolarize and 
contract at its maximum amplitude. Once the tissue had recovered, it would then be stretched 
to 50% of its maximum amplitude see figure 5.1. 
 
 
 
Figure 5.1 A trace showing how stretch was applied.  
High K+ 
50% 
50% 
Force Forc
e 
50% 
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The spontaneous and high K+ contractions in term singleton myometrium were superfused 
with physiological saline at 37 C and pH7.4. The arrows indicate increases in passive stretch 
in the tissue.  
100μM Progesterone was also added when the 50% of stretch was applied, and after every 4 
contractions another 50% of the maximum amplitude was added.  
The force, the percentage of the control force, duration and intercontractile interval was 
calculated for each sample  
The solutions protocols for the 100M progesterone and the physiological salt solution were 
the same as discussed in previous chapters. 
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5.4 Results 
 
Stretch appeared to reduce the effect of progesterone showing a lesser reduction in control 
force amplitude however this was not statistically significant when p≤0.05. See figure 5.2 
 
 
 
 
Figure 5.2 The effect of stretch on progesterone response 
The no stretch strip shows the effect of progesterone reducing the force of contractions. 
However when stretch was added in addition to progesterone the effect is reduced. 
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After application of progesterone the force amplitude and the percentage of control force 
were reduced in both groups however when stretch was combined with progesterone this 
effect was greatly reduced, with some values being three times the percentage in the no 
stretch group. The mean percentage of the original control for the stretch group was 52±18%, 
while the non stretch group was half this at 19±11.5% however this was not statistically 
significant p= 0.14 using paired student t test. See Figure 5.3  
 
 
 
 
Figure 5.3 A comparison of control percentage of control force where stretch was applied 
with progesterone or no stretch was applied with progesterone. (n=5) 
This figure shows that when stretch was applied with progesterone the reduction in the 
percentage of control force was not as great, and the effect of progesterone was reduced 
however this was not significant.  
 
 
 
 
% Control 
Force 
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The intercontraction interval was also slower in the stretch group, with the mean 
intercontraction interval of one contraction every 2± 0.4 minutes in the no stretch group, and 
4±1.4 minutes in the stretch group however this was not significant. The intercontraction 
interval was measured after the progesterone was added, either with stretch or without using 
the first three contractions. See figure 5.4 
 
 
 
 
 
 
 
Figure 5.4 The effect of stretch on intercontractile interval (n=5) 
 
 
 
 
 
 
 
 
 
 
Intercontractio
n interval 
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The duration of the first three contractions was shorter in the stretch group 0.44±0.04mins 
and 0.6±0.14mins in the no stretch group.  See figure 5.5 The effect of stretch on the 
duration.  
 
 
 
 
 
 
 
Figure 5.5 The effect of stretch on duration (n=5) 
The duration of the contraction was on average longer in the first three contractions in the 
group where no stretch was applied, however this was not significant. 
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5.5 Discussion  
 
One of the main differences between multiple pregnancies and singletons is the amount of 
stretch placed on the uterus with the multiple pregnancies having more fetuses to 
accommodate. This has led to the proposal that due to the higher levels of stretch earlier in 
pregnancy, contractile pathways are stimulated earlier leading to higher rates of preterm 
delivery. This theory was explored as a possible reason why progesterone was less effective 
in the twin myometrium as discussed in chapter four. 
 
As 100µM progesterone had the greatest effect in the progesterone samples compare to 1µM 
progesterone, this was used for the stretch protocol as this response had the greatest 
significant effect. The myometrial strips that had stretch as well as progesterone applied 
showed a higher percentage of original control force, the less the uterus was stretched. 
However my data did not achieve significance. This maybe due to a small sample size or due 
to the response of the myometrium to the progesterone, with some samples having a greater 
response to progesterone. The stretch applied in vivo is difficult to measure; although birth 
weight can be used, it does not include how much amniotic fluid was also in the uterine 
cavity or the size of the placenta. If the mother‟s fundal height is used then adipose tissue is 
also included. Therefore it is difficult to interpret how much stretch applied in vitro can also 
apply in vivo. However ultrasound has been used to measure the thickness of the uterus in 
twins, as uterine wall thickness is inversely proportional to uterine stress (Deyer et al 2000). 
This study found that preterm uterine thickness had a much thinner lower uterine segment 
than term twins, and that twins also had a thinner lower uterine segment compared to 
singletons (Sfakianaki et al 2008). 
 
Stretch has been shown to increase the expression of contractile associated proteins such as 
connexin 43 (Salameh et al 2010), and does appear to play strong part in the development of 
these pathways, whether or not it remains the trigger or is part of a more complex mechanism 
for preterm delivery remains to be seen.  
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5.6 Limitations and further work 
 
One of main difficulties was the requirement of both strips to behave in a similar manner for 
the limited time available to undertake this study and thus this data should be considered 
preliminary.  
 
Future work needs to explore how stretch can effectively be measured  in vivo in order to 
help fully understand the impact stretch has on the uterus, as otherwise the stretch theory will 
never be answered and its usefulness unknown. Although the use of animals at different 
gestational stages could help highlight the impact different amounts of stretch has on the 
contractile properties of the myometrium. Also the effect of stretch on PR isoform expression 
could be further explored or in twin and singleton myometrium. 
 
In vitro work could include similar experiments but with larger sample numbers, and explore 
the effect stretch has on other hormonal responses.  
 
5.7 Conclusion 
 
My preliminary data supports the hypothesis that stretch inhibits the effect of progesterone on 
uterine contractility. However further work is required to explore the true relationship of 
stretch and progesterone. 
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Chapter 6: Dietary advice for women with 
multiple pregnancies 
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6.1 Abstract 
 
Maternal nutrient insufficiency may be a possible reason for higher rates of preterm delivery, 
and an appropriate diet providing the mother and the fetus with adequate nutrition could 
decrease prematurity rates. Therefore a literature search was performed to evaluate what diet 
is appropriate for the mother to achieve optimal fetal outcomes. This search revealed that 
substantial information is still required. Higher weight gain in the first 20 weeks was 
associated with better fetal outcomes, and recommendations about weight gain should be 
determined by maternal pre-gravid BMI. However, there were differences in 
recommendations for quantities of weight gain. Dietary support and intervention may provide 
substantial benefits. However, still more research is required to determine the success of a 
high maternal weight gain against the potential harmful effects it could have on the mother.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
77 
 
6.2 Introduction 
 
1 in 15 pregnancies in the United Kingdom is a multiple pregnancy (ONS 2008), over 50% of 
which will deliver before 37 weeks. The perinatal mortality rate of multiple pregnancies is 
27.5 [95% CI 25.3,29.8] per 1000 total births, and the neonatal mortality rate is 20 
[18.1,22.0] per 1000 live births compared to the singleton perinatal mortality rate of 
6.9[6.7,7.1] per 1000 total births, and neonatal mortality rate 2.6[2.5,2.7] per 1000 live births. 
See table 6.1 for details of differences between triplet and higher order, twins and singletons 
(CEMACH 2008). 
 Triplets and higher 
order 
Twins Singletons 
Perinatal Mortality 
rate (per 1000 total 
births) [95%CI] 
 
81.8[59.0,113.4] 
 
27.2[25.0,29.5] 
 
6.9[6.7,7.1] 
Neonatal Mortality 
Rate (per 1000 live 
births) [95%CI] 
 
78.9[56.4,113.4] 
 
19.3[17.5,21.4] 
 
2.6[2.5,2.7] 
 
Table 6.1 Perinatal and neonatal mortality rates for twin, triplet and singletons (CEMACH 
2008) 
 
One of the main factors for the high mortality rates in multiple pregnancies is the higher rates 
of prematurity and its associated complications. Other factors include the increased incidence 
of intrauterine growth restriction and small for gestational age fetuses: 35.6% of twins and 
36.6% of triplets were small for gestational age compared to 9.4% of singleton deliveries 
(Alexander et al 1998). Small for gestational age neonates with low birthweights are more 
likely to develop visual, behaviour and growth problems throughout childhood (Monset-
Couchard et al 2004). 
 
When a neonate is small for gestational age possible causes include a pathological process, 
such as infection, pre-eclampsia or diet insufficiency. This can also be influenced by the 
chorionicity of the twins: monozygotic monochorionic twins can be complicated by twin-
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twin transfusion syndrome leading to severe growth discordance and ultimately 80% of 
fetuses will demise if left untreated (Duncan 2004). 
6.2.1 Maternal physiology and multiple pregnancies.  
 
Basal metabolic rate is greater in multiple pregnancies: 10% higher in twins than singletons, 
increasing with each trimester. There is also an increase in maternal plasma volume, fat 
soluble vitamins, triglycerides, cholesterol and free fatty acids.  
The placenta also secretes higher amounts of hormones and steroids which influence maternal 
carbohydrate metabolism, resulting in a more rapid uptake of glucose in the fetus causing 
accelerated depletion in the mother‟s glycogen stores (Goodnight et al 2009). 
Fat is metabolised due to the resulting shortage of glucose, to provide energy for growth and 
this results in ketonuria which is linked to preterm labor and delivery (Luke 2005). 
In early pregnancy, increased nausea and vomiting in twin pregnancies could hinder 
nutritional intake (Louik et al 2006). 
With the increased insulin resistance there is an increased the risk of gestational diabetes, 
which is associated with poor maternal outcomes and fetal macrosomia (Rosello-Soberon 
2005). 
 
6.2.2 Current clinical guidelines 
 
Currently the only clinical guidelines available are from the Institute of Medicine (IOM) in 
the USA. These guidelines are based on the mother‟s prenatal body mass index (BMI), 
calculated by weight(kg)/height(m
2
), and a recommended total pregnancy weight gain. See 
table 6.2 for IOM guidelines. 
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 Recommended Total Weight Gain 
 
Prepregnancy BMI 
Range in kg Range in lbs 
 
Normal weight 
(18.5–24.9 kg/m2) 
 
17-25 37-54 
Overweight 
(25.0–29.9 kg/m2) 
 
14-23 31-50 
Obese 
(≥ 30.0 kg/m2) 
 
11-19 25-42 
 
Table 6.2 IOM weight gain guidelines (Rasmussen 2009). 
 
However this guideline does not include underweight women, who are potentially at the most 
risk of inadequate nutrition. Another limitation of advising weight gain is the interpretation of 
this by the patient: the patient may opt for a diet high in saturated fats, which is associated 
with an increased risk of coronary artery disease and type 2 diabetes mellitus (Mann 2002).  
The IOM also states that there is insufficient knowledge to give full guidance for multiple 
births and more work is needed to help resolve this issue: when advocating a diet for multiple 
pregnancies it is necessary to consider the needs of the fetus as well as the implications of a 
high calorie diet on the mother‟s future health.  
Therefore the aim of this chapter is to review current literature on dietary advice for multiple 
pregnancies.  
 
 
 
 
 
 
 
80 
 
6.3 Methods 
 
A literature search was carried out using OVID Medline.  The inclusion criteria were: 
randomised controlled trials, 'quasi-random' studies, case-control, cohort, cross-sectional 
studies with multiple pregnancies (2 or more fetuses) either nulliparous or multiparous. The 
studies were selected if they focused on specialised diets or specific dietary advice for 
multiple pregnancies. The search strategy is included in the appendices. This produced 20 
reports using the above inclusion criteria, which was subdivided into twins or triplets, to take 
into account the different nutritional demands of triplet and twin pregnancies. 
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6.4 Results 
 
Table 6.3 summarises the method, and results of all the appropriate studies found.  
All studies found were cohort studies focusing on maternal weight gain/BMI and the fetal 
outcomes were small for gestational age, birthweight or preterm delivery.  
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Author Method Results 
B Luke et 
al 2003 
Cohort Study of 2324 twin pregnancies.  
Inclusion criteria were; 
1. Two twins born alive 
2. ≤28 weeks first ultrasonography or best 
clinical estimate 
3. Documented birthweights and sexes 
4. At least two ultrasonographic weight 
estimates first before 28 weeks 
5. Absence of major congenital 
abnormalities 
6. BWT discordancy<20% 
7. Documentated maternal height, and at 
least 2 maternal weights, one prenatal , 
one 1 week after delivery.  
Regression curves created for maternal and fetal 
weight gain. 
Optimal Weight gain that caused optimal fetal growth 105-110g/wk 20-28 weeks, 28 until delivery 155-
161g/wk and optimal birthweights 36-38week gestation  2850-2928g: 
Underweight women (BMI<19.8) 
0-20wks 1.25-1.75lb(0.57-0.79kg/wk 
20-28wks 1.5-1.75lb/wk(0.68-0.79kg/wk) 
29-delivery 1.25lb/wk (0.57kg/wk) 
Normal Weight(BMI 19.8-26) 
0-20wks  1-1.5lb/wk(0.45-0.68kg/wk) 
20-28wks 1.25-1.75lb/wk(0.57-0.79kg/wk 
29-delivery 1lb/wk (0.45kg/wk) 
Overweight (26.1-29.0) 
0-20wks 1-1.25lb/wk(0.45-0.57kg/wk) 
20-28wks 1-1.5lb/wk (0.45-0.68kg/wk) 
29-delivery 1lb/wk( 0.45kg/wk) 
Obese (BMI>29.0) 
0-20wks 0.75-1lb/wk (0.34-0.45kg/wk) 
20-28wks 0.75-1.25lb/wk(0.34-0.57kg/wk) 
29-delivery 0.75lb/wk(0.34kg/wk) 
Table 6.3 Results of twin search 
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Luke et al 
1997 
Cohort Study of 646 twin pregnancies >28 wks 
Inclusion Criteria: 
1. Both twins born alive 
2. >28 weeks' gestation by last menstrual 
period, first-trimester ultrasonography, 
or best obstetric estimate (a combination 
of clinical and ultrasonographic 
estimates) 
3. Documented genders and birthweights  
4. Absence of major congenital anomalies 
as documented by normal findings,  
5. Documented maternal height and weight 
within 1 week of delivery. 
Birth weight was significantly associated with weight gain before 20 weeks in underweight women, before 
20 weeks and after 28 weeks in overweight women, and during all three gestational periods in normal-
weight women. Weight gain before 20 weeks had the largest effect on infants of underweight women, less 
of an effect on infants of normal-weight women, and half as much effect on infants of overweight women. 
Weight gain after 28 weeks significantly affected the infant birth weights of normal-weight and overweight 
women, but the effect was half as great among infants of the latter group. 
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Lantz et al 
1999 
Cohort of 189 twin pregnancies 
Inclusion Criteria: 
1. Maternal recall of pregravid weight and 
height, at least 3 prenatal visits 
2. Delivery after 28 weeks gestation 
3. Birthweights for both fetuses 
4. A prenatal weight measurement within 
two weeks of delivery 
Exclusion Criteria: 
1. Diabetes Mellitus, Hypertension 
2. Gestational Diabetes, pre-eclampsia, 
fetal death 
3. Congenital anomalies 
Outcome variable both twins at least 2500g at 
delivery.  
Multiple logistic regression performed.  
Rates of Weight gain, that were associated with fetal birth weight over 2500g. 
BMI<19.8  
0-20wks  1.13±0.24lb/wk, 20+wks 1.92±0.62lb/wk 
BMI19.8-26.0 
0-20wks 0.61±0.12lb/wk, 20+wks 1.63±.15lb/wk 
BMI>26.0 
0-20wks  0.46±0.14lb/wk, 20+wks 1.85±0.27lb/wk 
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Luke et al 
2003 
Prospective interventional study 
Exclusion criteria: 
1. Monochorionic twins 
2. Pregnancies in which the mother had 
been transferred as an emergency with 
pregnancy complications from outlying 
hospitals at the time of delivery 
3. Fetal death 
4. Major congenital fetal anomalies 
Intervention: Specialised diet education  
 Twice monthly prenatal visits to 
registered dietician and nurse 
practitioner in addition to normal 
prenatal visits 
 Additional maternal education 
 Modification of maternal activity 
 Individualised dietary prescription 
 Multimineral supplementation 
 Serial monitoring of nutritional status 
180 pregnancies in intervention group, 320 in non 
intervention group.  
 
 
PPROM  
Preterm Labour 
Delivery < 36 wk  
Delivery < 32 wk  
Delivery < 30 wk  
LBW  
VLBW  
Non-LBW 
Length of gestation (d) 
 
Average birth weight (g) 
Intervention 
group %: 
10 
23 
41 
7 
3 
41 
5 
59 
 
251.0±1.3 
 
2467±37 
Non 
Intervention 
group (%) 
25 
42 
53 
21 
9 
64 
16 
36 
 
243.6±1.3 
 
2217±36 
P Value 
 
<0.0001 
<0.0001 
0.1 
<0.0001 
0.1 
<0.0001 
0.001 
<0.0001 
<0.0001 
 
<0.0001 
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Dubois et 
al  1991 
A cohort study of 177 women with twin 
pregnancies who received Higgins Nutritional 
programme and 354 non-intervention twins 
pregnancies 
Programme education which consists of: 
1. An assessment ofthe risks for the 
presenting pregnancy 
2. The determination of individual dietary 
requirements based on the combination 
of the normal requirementsof pregnancy 
and rehabilitation allowances for 
diagnosed risk,  
3. Teaching of food-consumption patterns 
that meet individual dietary 
requirements while respecting 
preexisting food habits 
4. Follow-up and supervision by the same 
dietician at 2 to 4-wk intervals. 
 
 
Birth weight (g)  
 
Low birth weight (%)  
Very Low birthweight (%) 
Preterm(%) 
Very Preterm(%) 
IUGR(%) 
Higgins 
Group 
2468±559 
 
47 
5 
40 
8 
14 
 
Non intervention 
 
2378±620 
 
55 
9 
47 
16 
18 
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Luke et al 
1998 
Cohort study 
1564 twins medical records reviewed to evaluate 
effect of pregnancy weight gain on  
Inclusion criteria: 
1. both twins born alive 
2. >28 weeks‟ gestation by last menstrual 
period, first trimester ultrasonography, 
or best obstetric estimate (a combination 
of clinical and ultrasonographic 
estimates 
3. documented genders and birth weights  
4. absence of major congenital anomalies 
as documented by normal findings 
Increased mid fetal growth was associated with early maternal gain (10.91g/wk per pound per week) and 
mid maternal gain (15.89 g/wk per pound per week). Increased late fetal growth was associated with early 
maternal weight gain (16.86g/wk per pound per week) and mid maternal weight gain (23.88 g/wk per 
pound per week). The rate of late maternal weight gain did not contribute significantly to the rate of late 
fetal growth (2.51 ± 3.01 g/wk per pound per week, P = .40)and therefore was not retained in the final 
model of rateof late fetal growth 
The low pattern of maternal weight gain (5lb by 20 weeks, 13 lb by 28 weeks, and 25 lb by 36 weeks) 
resulted in an estimated sum of fetal weights of 2216 g (1108 g per twin, 43rd percentile for gestational age, 
on the basis of the twins in the study population) by 28 weeks and an estimated sum of birth weights of 
4541 g(2270 g per twin, 37th percentile for gestational age) by36 weeks. With the mean pattern of maternal 
weight gain(15 lb by 20 weeks, 27 lb by 28 weeks, and 39 lb by 36 weeks), the estimated sum of the fetal 
weights was 2323 g(1162 g per twin, 56th percentile for gestational age) by28 weeks and the estimated sum 
of birth weights was 4811g (2405 g per twin, 54th percentile for gestational age) by 36 weeks. With the 
high pattern of maternal weight gain(25 lb by 20 weeks, 41 lb by 28 weeks, and 53 lb by 36weeks), the 
estimated sum of fetal weights was 2430 g(1215 g per twin, 68th percentile for gestational age) by 28 
weeks and the estimated sum of birth weights was 5081g (2541 g per twin, 69th percentile for gestational 
age) by 36 weeks. 
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Pederson 
et al 1989 
Cohort study of twin pregnancies to identify the 
optimal weight gain and pattern for normal twin 
gestations 
Optimal outcome was defined as: 
Pregnancy at least 37 week gestation with 
delivery of two living twins ≤2500g each with a 5 
minute Apgar ≥7.  
Exclusion criteria: 
 Diabetes Mellitus 
 Major Infection 
 Organic Heart Disease 
 Drug Addiction 
 Accident during pregnancy 
 Maternal age<18 years old 
Mean Weight Gain for optimal fetal outcome 20kg(44lb), the mean weight gain with less than optimum 
fetal outcome was 16kg(37lb) 
Rate noticeably declined in less than optimal groups at 30 weeks.  
No significant difference between zygosity 
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6.4.1 Twin search results 
 
Luke et al 2003 used a large cohort of 2324 twin pregnancies to produce multiple regression 
curves using maternal pregravid weight, and postpartum weight within 1 week of delivery, 
and at least two ultrasonographic weight estimates. They used this information to decide what 
weight gain lead to the best outcomes, for example fetal birth weight 2850-2928g, gestation 
36-38 weeks. This was subdivided based on the mothers‟ prenatal BMI: underweight (<19.8), 
normal (19.9-26.0), overweight(26.1-29.0) and obese(>29.0). It was found that in the 
underweight group a greater weight gain was required to achieve optimum fetal outcomes, 
and greater rate of weight gain was required up to 20 weeks. Not surprisingly, less weight 
gain was needed for the obese and overweight groups: see table 6.4. 
 
 0-20wks 
lb/wk(kg/wk) 
20-28wks 
lb/wk(kg/wk) 
29wks –delivery 
lb/wk(kg/wk) 
Overweight (26.1-
29.0) 
1-1.25 (0.45-0.57) 1-1.5 (0.45-0.68) 1 (0.45) 
 
Obese (BMI>29.0): 0.75-1 (0.34-0.45) 0.75-1.25 (0.34-0.57) 0.75 (0.34) 
 
Table 6.4. Luke et al 2003 weight gain recommendations for the overweight and obese in 
twin pregnancies 
However these regression curves were made only using two maternal weight gains recorded 
prenatally or post partum after 1 delivery, this does not take into account weight that may 
have been gained then lost during pregnancy at critical moments of growth i.e. 20 or 32 
weeks, as the mother may have gained the appropriate weight but may not have met the 
demands needed by the fetus later on.  
This study also does not take into account where this weight gain came from, as it may come 
from water retention, or build up of fat or muscle. BMI is also not a good indication of the 
health of the mother, as it is unable to distinguish between fat and muscle mass. (Romero-
Corrral et al 2008). Subsequently this muscle may have been lost during pregnancy if the 
mother became less active, introducing bias into the data, as it would not have shown true 
weight gain. Also it should be noted the fetal regression curves used ultrasonographic data, 
and are prospective. Operator bias could have been introduced by different levels of skill of 
the ultrasonographers, and therefore inaccuracies of estimates of birthweight.  It does 
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however have a large study group which strengthens the power of the study, yet with 
measuring BMI at the start and the end points it does not show the full picture of maternal 
BMI throughout pregnancy. 
Earlier work by Luke (Luke et al 2003) found that the timing of the weight gain was 
significant, and in underweight mothers, weight gain in the first twenty weeks made a 
significant impact on fetal birth weight, with the first and last trimester weight gain having 
the biggest influence in mothers who had an overweight pregravid BMI, and that all three 
trimester periods were important in normal pregnancies. This suggests that maternal nutrition 
in the first 20 weeks of pregnancy is very important, and has the greatest influence on fetal 
birth weight, as this may be due to vital „foundations‟ being formed to enable optimal growth.  
If there is nutrient insufficiency early on it leads to poor placenta growth and therefore poor 
delivery of nutrients to the fetus. However it is interesting that there was no significant rate of 
weight gain found for underweight mothers after twenty weeks considering there was a 
significant difference in the normal and overweight group. This earlier weight gain is 
supported by another study by Luke et al 1998 concluded that a higher 20week weight gain of 
10lb was associated with higher fetal birthweights (2430g compared to 2323g).  
Lantz et al 1999 also looked at maternal BMI as an independent factor for the fetal outcomes. 
A lower rate of weight gain was associated with fetal birthweight over 2500g. However this 
study size was smaller than Luke et al 2003. Birthweight was the only „optimum fetal 
outcome‟ studied – in contrast to  Luke who had also included 36-37 week gestation as an 
optimal outcome, so this would have influenced the data. Lantz et al actually found that a 
lower rate weight gain than the rate recommended by Luke et al was successful to achieve 
over 2500g in the underweight women with a BMI<19.8  compared to those with a 19.8-26 
or  >26. Their rate was calculated from twenty weeks by subtracting the maternal 20 week 
weight from last known maternal weight before delivery, and dividing by twenty, however it 
is unclear what gestations these weight were recorded.  
Pedersen et al 1989 also found that a weight gain of 20kg compared to 16kg led to a better 
fetal outcome; two fetuses over 2500g and gestation of 36-37 weeks. It was also noticed that 
there was a decline in the rate of growth from 30 weeks in the less than optimal weight gain 
group.  
 
 
 
 
 91 
 
6.4.1.1Dietary intervention in twins 
 
As discussed earlier the majority of studies focused on the association between maternal 
weight gain and fetal outcome, rather than the direct effects of nutritional advice, however 
two studies were found that used dietary intervention to help improve fetal outcome.  
One study by Luke et al in 2003 used a specialised diet tailored to the individuals weight, and 
advocated a rate of weight gain dependent on their maternal pregravid BMI, 4000 kcal/day 
for underweight, 3500kcal/day for normal weight, 3250kcal/day for overweight and 
3000kcal/day for obese. 20% of calorie intake was from protein, 40% carbohydrates, and 
40% from fat. Table 6.1 gives full details of the rate of weight gain recommended. It was 
found that there were significant differences in between the groups, and that dietary 
intervention improved fetal outcomes, see table 6.3 for more details. Preterm labour was 10% 
in the intervention group compared to 25% in the non intervention group. There were also 
significantly fewer  low birth weight babies in the intervention group. However there was no 
information on maternal health after such a high calorie diet, and what implications this 
might have had on their mental well being.  It is difficult to say if this high weight gain was 
actually achieved, or if the reduction in preterm labour was a result of maternal education or 
of a healthy diet.  
 
A similar intervention was tried using the Higgins Nutritional programme where a specialised 
diet was created dependent on the mothers‟ risk factors, and the demands of pregnancy. There 
were lower rates of low birth weight and preterm labour in the group that received the 
Higgins nutrition intervention programme. There were no significant differences found apart 
from when the results were adjusted for confounding bias, and then it was  found that the 
odds ratio was significantly different in the intervention group for low birth weight, very low 
birth weight and preterm delivery, 0.73(0.55-0.99), 0.53(0.29-0.97), 0.68(0.51-0.92) 
respectively.  
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6.4.2 Triplets 
 
Similar results were seen in the triplet search with the all the studies being cohort, and 
focusing on maternal weight gain rather than the factors that affect it, i.e. calorie intake, and 
diet composition.  
Blickstein et al 2005 focused on the differences of maternal weight gain between the 5
th
 and 
1
st
centile of neonatal birthweights, finding there was no significant difference between 
maternal weight gain between the two different centile groups. Table 6.5 shows the results of 
the studies found for the triplets, and gives more details of this study.  
Flidel Ramon et al 2006 also found that an early weight gain was not associated with 
significant difference in birthweights for normal pregravid BMI triplet pregnancies, although 
the percentage for small for gestational age did decrease as the average weight gain 
increased.  However rather than use each triplet‟s individual birth weight, the birth weight 
outcome was a total of all three triplets‟ birthweights combined, which would hide any 
discordancy and a triplet with a low birth weight could potentially be hidden by a triplet with 
a high birth weight and not show the true outcome. 
Maternal BMI and the rate of weight gain was also shown to be insignificant in triplets in a 
cohort study evaluating 38 triplets by Luke et al 1995. It was found that maternal pregravid 
BMI did not influence the gestation of the triplets, and earlier maternal weight gain at a lower 
rate did not lead to more preterm triplets, and that the lower rate of weight gain was in the 35-
37weeks gestation group. However other work by Luke et al 2002 using a larger cohort of 
178 triplets found that if women had a BMI of <26.0 and had not gained 36lbs by 24 weeks 
gestation there was significantly reduced fetal growth and birth weight. Also a birth weight 
≤25thcentile was significantly associated with a shorter gestation in all weight groups.  
Eddib et al 2007 also studied the impact of maternal weight gain and BMI on fetal weight 
gain. Total maternal weight gain of 15kg or more significantly increased the length of 
gestation and the mean fetal birth weight, however maternal pregravid BMI did not 
significantly affect fetal outcome.  
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Author Method Results 
Blickstein 
et al 2005 
Cohort 2850 triplets No significant difference between average maternal weight gain between the 5
th
 and 1
st
 decile of  neonates birth weight 
Weight Gain greater than 0.68 kg/week 15.3% (5
th
 decile) 13.0%(1
st
 decile) OR 1.2 (0.7, 2.0) 
Flidel-
Rimon et 
al 2006 
Retrospective observational study 
of1166 triplet mothers with a 
normal (19.8–26) pregravid BMI. 
Weight gain categorized into three 
groups: 
 Adequate if the average 
exceeded a weekly weight 
gain of 680 g 
 Average if less than 
recommended weight gain 
500-680g/wk 
 Inadequate if weight gain 
below average<500g/wk. 
 
 
 
 
≥1 Small for gestational age 
 
Total birth weight <4500g 
Weight gain (g/wk)  
 
500(A)        500–680(B)     680(C) 
 
17.6%            14.2%            13.9% 
 
 26.9%            21.6 %             20.2% 
Statistics(OR) 
 
A vs. B      B vs. C            A vs. C 
 
1.2 (0.9, 1.9) 1.6 (0.9, 2.7) 1.3(0.8, 2.1) 
 
1.3 (0.9, 1.8) 1.4 (0.9, 2.1) 1.4 (0.9, 2.2) 
Table 6.5 Results of triplet search 
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Levy 
2007 
Retrospective observational study of 
triplets: 
1235 nulliparas 
and 705 multiparas.  
The difference between the 
pregravid body mass index (BMI) 
and at 16–25 weeks‟ gestation was 
averaged to obtain the weekly 
change in BMI, defined as slow, 
typical,or fast by values -1SD, 
"1SD, and )1SD from the mean 
average weekly change in BMI. 
Weight Gain 
 
Gestational Age(weeks) 
 <28 weeks 
 28-32 
 >32weeks 
Birth weight 
 <1000 
 1000-1500 
 >1500 
SGA ≥1 
Discordance>25% 
Slow         Typical      Fast 
 
 
8.0%         4.2%      3.0%  
 40.7%      38.6%     40.0% 
50.8%       57.6%    57.2% 
 
11.9%            6.3%         5.1%   
25.7%           21.8)%    19.7% 
62.3%           71.9%      75.% 
25.9%           18.2%   14.6%  
47.5%           45.5%     45.1%  
Statistics 
S vs. T           S vs. F          T vs. F 
 
NS              NS            NS 
NS              NS            NS 
NS              NS            NS 
 
2.0 (1.4–2.8) 2.5 (1.5–4.2) NS 
NS              1.4 (1.1–1.9)    NS 
2 0.6 (0.5–0.8) 0.5 (0.4–0.7) NS 
 1.6 (1.1–2.4) 2.0 (1.1–3.7) NS 
NS              NS                   NS 
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Luke et al  
1995 
Cohort study of 38 triplets to access 
the effect of maternal weight gain 
on fetal birth weight 
Inclusion criteria: 
 Complete data of maternal 
height, pregravid weight, 
last menstrual period 
 Expected date of delivery, 
actual date of delivery 
 Prenatal weights at 
24weeks or at 23,25 weeks 
gestation 
 Last recorded weight 
within 1 week of delivery 
 Birthweights of all three 
triplets 
 
                                                                                     
Body mass index(BMI) 
 
Underweight<19.8(%) 
Normal (19.8-26.0) (%) 
Overweight (>36.0) (%) 
 
 
 
Rate of gestational weight gain/week 
Before 24 weeks 
After 24 weeks 
 
 
No significance found  
 
27-30weeks        31-34weeks       35-37weeks     
 
14.3                       17.6                     35.7 
71.4                       82.4                     57.1 
  14                        3 0                        7.1 
 
 
 
1.13±0.2             1.10±0.5               0.97±0.3 
1.69±0.6             2.38±1.4              1.99±1.2 
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Luke et al  
2002 
Cohort of 178 triplet pregnancies to 
evaluate maternal factors on triplets 
outcomes 
Inclusion criteria: 
 ≥24 gestation 
 1st trimester ultrasound 
 Documented maternal 
height, pregravid weight 
 Prenatal weights at each 
visit, inc within 1 week of 
delivery 
                                                                     Underweight              Normal weight                      Overweight 
                                                                     (BMI <19.8)              (BMI 19.8-26.0)                     (BMI >26.0) 
Change in average rate of fetal growth (g/wk) 
Rate of maternal weight gain 
0-24 wk                                                       +7.4 (4.8) [.14]            +7.5 (2.0) [<.0001]                  +2.5 (1.6) [.13] 
24 wk-delivery                                             +1.1 (2.1) [.61]            +1.7 (0.7) [.02]                       +2.1 (1.1) [.07] 
<36 pounds by 24 wk                                  –7.7 (3.3) [.02]             –6.6 (1.9) [.001]                     –2.7 (2.4) [.26] 
Change in average birth weight (g) 
Rate of maternal weight gain 
0-24 wk                                                        +274.3 (166.9) [.11]      +236.9 (66.1) [.001]            +73.5 (49.2) [.15] 
24 wk-delivery                                             +40.2 (73.5) [.59]          +48.5 (25.3) [.05]                +62.0 (38.9) [.08] 
<36 pounds by 24 wk                                   –297.5 (110.5) [.01]     –222.0 (61.2) [.001]            –81.0 (73.3) [.28] 
Change in length of gestation (d) 
Rate of fetal growth g/wk 
≤ 25th percentile <45g/wk                     –37.3 (5.8) [<.0001] –38.6 (4.3) [<.0001]         –35.8 (8.2) [<.0001] 
≥75th percentile: >61 g/wk                  +10.9 (11.9) [.37]        +20.4 (5.9) [.001]           +24.5 (8.8) [.009]  
 
Values are presented as β coefficients, (SE) [P value] 
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Eddib et 
al 2007 
Cohort of 56 triplet pregnancies  to 
evaluate the relationship of 
Maternal BMI and weight gain on 
fetal outcomes 
Weight Gain                                      Gestational Age At Delivery                                Mean Triplet Birth weight 
                                                   Median                   IQR                                               Median                   IQR 
<15.9kg                                       28.4                    24.1-32.8                                           1231                   624-1717 
15.9-20.5kg                                 33.1                    31.9-33.8                                           1945                 1495-2317 
>20.5kg                                       33.1                    31.7-34.4                                           1951                 1586-2279 
 
                                                                                           P value=0.004                                              P value=0.001 
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6.5 Discussion 
 
6.5.1 Twins 
 
Having completed the literature search, we found no randomised controlled trials, and very 
few of the cohort studies which focused on the effects of dietary advice rather than the 
association between different amounts  of maternal weight gain and fetal birth weight. 
Maternal BMI should be taken into consideration as underweight mothers are more likely to 
have poor rates of fetal growth, especially in the first 20 weeks, if there inadequate weight 
gain. However, how much weight gain is required needs to be decided as there are varying 
recommendations: Luke et al (Luke et al 2003) and Lantz et al (Lantz et al 1999) both found 
that optimal fetal weight in the first 20weeks was achieved by a rate of maternal weight gain 
of 1.25-1.75 lb/wk and 1.13lb/wk respectively, and a higher rate after 20 weeks of 1.5-
1.75lb/wk and 1.92lb/wk respectively. However the optimal fetal birth weight was defined as 
different weights, Luke et al 2850-2928g compared to >2500g by Lantz et al. 
However these results were calculated by using regression curves and the mother‟s weight 
was only measured prenatally, and postpartum within one week of delivery; there was not a 
direct weekly measure of weight.  
A high total weight gain of 53lb was also associated with a birth weight greater than 2500g 
by 36 weeks, with a lower weight gain of 25lb achieving a birth weight of 2270g. 
The data suggests that a higher maternal weight gain results in a higher fetal birth weight, and 
it is important that there is adequate nutrition in the first 20 weeks, yet not all women will be 
aware they are having a twin pregnancy until 10+ weeks, so vital time to help growth will be 
lost.  
The difficulty in using weight gain as a measure of growth is that it does not reflect where 
there is actual growth occurring; the mother maybe increasing adipose tissue rather than the 
fetus. It does not necessarily give the full information about the diet the mother requires in 
order achieving the appropriate weight gain. The maternal weight measured did not take into 
account the size and weight of the placenta. If there is a damaged placenta then the rate of 
maternal weight gain would not matter. Zygosity was also found not to be a significant issue 
by Pederson et al however this was focusing on normal twin pregnancy. None of the studies 
excluded monozygotic twins.  
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Two studies compared the effect of dietary intervention; either creating a specialized diet 
dependent of pregnancy risk factors or using a diet dependent on the mother pregravid BMI.  
Both found that the intervention improved fetal outcome such as preterm delivery, and low 
birth weight.  Both interventions also required regular follow ups with the dietician and to 
create an individualized diet. However in the Luke group they were also given multivitamin 
supplements, so it is hard to clarify if these improved fetal outcomes were as a result of 
regular visits with the dietician, or the high daily calorie intake of 4000-3000kcal a day or the 
use of multivitamins. One concerning aspect of such a high calorie diet is the postpartum 
weight the mother will have, and how this will affect her mental well being, and future 
health. Many women will also suffer from severe nausea and vomiting, and it would not be 
practical to „force feed‟ women who are already struggling to obtain a normal dietary intake. 
However this may indicate that other supplementation could be used such as Ensure, and 
other nutrient drinks in order to supply the fetus with the appropriate nutrients. 
The cost of a healthy high calorie diet also needs to be taken into account, as twin 
pregnancies are financially demanding. Ideally, 40% of the calories intake would be from 
protein, which would be obtained from meat such as chicken (or lentils if vegetarian) which 
would also increase the costs.  
 
6.5.2 Triplets 
 
There is a large deficit in knowledge for triplet nutrition, there were no trials found evaluating 
the diet of triplets only weight gain that led to the greatest fetal birth weight. It can only be 
presumed that as a result of having three or more growing fetuses that there is a greater 
demand for nutrition than in twins and it is important to have a healthy high calorie diet.  
What the studies do show is that maternal pregravid BMI does not have a significant effect on 
fetal outcome, but a fast rate of weight gain and total weight gain of 15.9kg or more are 
associated with a longer gestation and larger mean birth weight. However the weight gain 
may not necessarily be a cause of poor rate of growth more an indication of how effective the 
utero-placenta unit is, showing that the fetuses are receiving enough nutrients to be able to 
grow from a healthy placenta.  
 
6.6 Limitations and further work 
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This review showed that there was a severe shortage of studies accessing the dietary 
requirements required, as this limits our ability to review what current information known, 
and to develop appropriate guidelines. It may be that more baseline differences between 
multiple births and singleton physiology needs to be quantified so singleton research can be 
used to aid dietary advice for multiple births. However it is clear that more work needs to 
done to validate such a high calorie intake for twin mothers, and more maternal outcomes 
need to be included, as the reality of such a high calorie diet without all the dietary support 
will large quantities of mothers eating high fat foods in order to obtain the calories yet 
damaging their future health.  
Also maternal education of a healthy pre-pregnancy diet will improve growth in early 
pregnancy also needs to evaluated as not all twin pregnancies are planned. 
 
6.7 Conclusion 
 
High amounts of maternal weight gain are associated with higher birth weight in twins, and 
that higher amounts of weight gain are required if the mother is underweight, and less if 
obese. During the first twenty weeks of pregnancy it is important that the mother has a 
healthy diet, however more research is required to in multiple births about diet content. It is 
also important to have a supportive network of dieticians to help educate mothers about 
having a healthy diet, and finding an economical way to achieve this.  
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Chapter 7: Final Discussion 
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Final Discussion 
 
Preterm labour and preterm delivery are the greatest risks in multiple pregnancies, and 
therefore there are higher rates of associated perinatal mortality and morbidity. However, 
despite the many advances in science; the mechanism that causes early delivery in twins and 
triplets or even in singletons is still unknown.  
Previous work has shown that twin myometrium has a longer duration (Turton et al 2008), 
and daily uterine monitoring systems have shown a higher basal mean frequency of 
contractions compared to singletons. However on comparison of in vitro myometrial 
contractile properties of multiple and singleton pregnancies there were no significant 
differences. It should be noted that the triplet sample number was limited. The preterm 
samples collected also showed no significant differences to the term group; however, these 
sample numbers were small, and difficult to obtain. Yet this lack of significant difference 
between contractile myometrial properties suggests that some other process is occurring in 
vivo.  
On comparing the effects of progesterone between singleton and twin myometrium, 
significant differences were found at 10µM and 100µM progesterone, with progesterone 
having less of an effect in reducing the force of control contractions in twin myometrium 
with a dose response relationship. As progesterone trials have found it to be effective in 
singleton high risk pregnancies in reducing preterm birth (Meis et al 2003), but not in 
multiple pregnancies (Norman et al 2009, Caritis et al 2009, Briery et al 2009), a higher dose 
of progesterone may be required to have a similar effect.  This difference allows us to further 
our understanding of the different myometrial properties and start to cast some light on the 
complex pathway of labour.  
Other in vitro work has had success with progesterone metabolites to reduce the force and 
frequency of uterine contractions (Thornton et al 1999), as well as progesterone (Anderson et 
al 2009). My work has also helped support the theory of progesterone‟s ability to reduce the 
force of uterine contractions in vitro. 
The next step maybe would be to see if a higher dose of progesterone would make a 
significant difference in vivo, however the risk-benefit ratio of giving higher doses of 
progesterone needs to be considered.  
This difference in effect could be due to a reduction in progesterone membrane receptor 
expression as a result of greater amounts of stretch, thus reducing levels of cAMP and 
causing a more „active uterus‟. However it is likely that it is not this simple and a 
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combination of factors occur that reduce the expression of membrane progesterone receptors. 
The effect of stretch was not found to be significant; however, this finding was limited by a 
small sample size.  
The stretch theory has not yet been fully established as a trigger for preterm delivery and 
future works needs to find an appropriate method to help quantify this, to help determine the 
effect stretch has on the uterus. 
If stretch is one of the mechanisms that trigger contractile pathways leading to preterm 
delivery, it is interesting to consider the effect the high calorie diet recommended by Luke et 
al would have on preterm delivery, as it was found that a higher rate of maternal weight gain 
before 20 weeks led to higher rates of fetal growth, and final birth weight. These mothers that 
are achieving higher rates of fetal weight gain early in pregnancy are also placing having 
greater amounts of stretch placed on the uterus.  This is another subject that there is a lack of 
knowledge, and requires further research. Despite the success of the intervention studies it is 
difficult to clarify whether or not a diet of 4000kcal or less is achievable without the 
necessary support, for example regular dietician meetings, or how practical and achievable it 
is for the patient. The maternal outcomes also need to be taken into consideration, as the high 
weight gain will likely impact the future health of the mother. 
 
I hope my work has helped to answer a few of the many questions that arise around multiple 
pregnancy, and shed some light on a possible pathway that leads to early uterine preterm 
labour.  
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Appendices 
 
Appendix A: Patient characteristics of samples 
 
Maternal 
Age Gestation P G BMI Twin/Singleton Elective/Emergency C- section 
28 39 1 2 30.2 Singleton Elective 
34 39 1 4 33.9 Singleton Elective 
24 39 1 2 22.1 Singleton Elective 
28 39 1 2 42.1 Singleton Elective 
36 39.1 1 2 23.8 Singleton Elective 
23 35 0 1 19.3 Singleton Elective 
36 39 1 2 21.6 Singleton Elective 
29 39.4 2 3 18.1 Singleton Elective 
33 39 3 4 22.7 Singleton Elective 
26 39 2 1 28.7 Singleton Elective 
40 36 0 1 22 Singleton Elective 
26 39 1 2 29.3 Singleton Elective 
37 39 2 7 25.8 Singleton Elective 
27 36.2 2 3 16 Singleton Elective 
37 37.4 0 3 30.9 Singleton Elective 
28 39.6 1 1 24 Singleton Elective 
24 39 0 3 21.2 Singleton Elective 
32 39 1 3 26.2 Singleton Elective 
36 37 6 7 34.2 Twin Elective 
20 37 0 1 27.2 Twin Elective 
34 35.4 1 3 24.8 Twin Elective 
34 37.5 0 1 22.6 Twin Elective 
44 36.4 2 2 31 Twin Elective 
29 37.2 1 2 28.8 Twin Elective 
33 37 0 2 24.2 Twin Elective 
33 37.6 0 1 23.2 Twin Elective 
28 32.4 3 5 22 Triplet Elective 
40 32 0 1 25 Triplet Elective 
20 31 2 1 23 Singleton Emergency 
29 27 0 1 26.2 Twin Emergency 
 
 
 
 
 
 
  
 
Appendix B: Search strategy for dietary advice 
Database: Ovid MEDLINE(R) and Ovid OLDMEDLINE(R) 1948 to Present with Daily Update 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     Epidemiologic studies/ (4646) 
2     exp case control studies/ (460485) 
3     exp cohort studies/ (757520) 
4     Case control.tw. (50039) 
5     (cohort adj (study or studies)).tw. (45539) 
6     Cohort analy$.tw. (2198) 
7     (Follow up adj (study or studies)).tw. (30311) 
8     (observational adj (study or studies)).tw. (22402) 
9     Longitudinal.tw. (91677) 
10     Retrospective.tw. (175360) 
11     Cross sectional.tw. (96301) 
12     Cross-sectional studies/ (109655) 
13     or/1-12 (1347089) 
14     exp Diet/ (155052) 
15     diet$.mp. (401494) 
16     exp Dietary Supplements/ (24122) 
17     ((prenatal$ or antenatal$) adj2 (nutrition$ or nutrient$ or supplement$)).ti,ab. (496) 
18     exp Weight Gain/ (17145) 
19     exp Pregnancy, Multiple/ (24752) 
20     (twin$ or triplet$).ti,ab. (43225) 
21     (multiple adj pregnancy).ti,ab. (1654) 
22     14 or 15 or 16 or 17 or 18 (443790) 
23     19 or 20 or 21 (50768) 
24     13 and 22 and 23 (211) 
25     limit 24 to humans (209) 
26     from 25 keep 1-209 (209) 
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Appendix D: Copy of consent form  
 
Consent form 
Collection and Storage of Tissue for Research 
 
 
Myometrial Research Tissue Bank, University Department, Liverpool Women’s NHS 
Foundation Trust, Liverpool L8 7SS. Tel: 0151 702 4100  
 
 
  
 
I (print name):………………………………………………………………………………of  
 
Address: …………………………………………………………………………………………. ….. 
 
Please initial 
I have read and understood the Information Leaflet (version 1) about 
the use of tissue removed at my caesarean section for research 
purposes and have been given a copy to keep.  
 
 
I agree that Liverpool Women’s NHS Foundation Trust will become the 
custodian of this tissue and that it will be used in regulated research 
projects following anonymisation (I will not be identifiable to the 
researcher) and subject to separate ethical approval.  
 
 
I give permission for medical records that relate to my pregnancy / 
labour to be periodically examined and relevant information taken from 
them to be used in approved research projects. 
 
 
I understand that any information about me will be treated 
confidentially and stored securely.  
 
 
Neither the Research Tissue Bank nor I will benefit financially if this 
research leads to new treatments or medical tests.  
 
 
I understand that I may, at any time, withdraw my approval for tissue 
and information to be stored and used for research without giving any 
reason and without it affecting my medical treatment. 
 
 
Signed ……………………………………………………………………Date……………..  
 
I have explained the request for research purposes and answered such questions as the 
patient has asked.  
 
Clinical Practitioner  
 
Signed ……………………………………. 
 
Print Name……………………………… 
 
Date……………… 
 
